Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CR2,Complement receptor type 2,Lifestyle factors,X1050.Time spend outdoors in summer,48920,-0.0647957590139751,0.0233115572530787,-0.110486411230009,-0.0191051067979408,0.00544749529476368
CR2,Complement receptor type 2,Lifestyle factors,X1060.Time spent outdoors in winter,45230,-0.0293158071845111,0.0266002346580316,-0.081452267114253,0.0228206527452309,0.270436054875482
CR2,Complement receptor type 2,Physical activities,X1070.Time spent watching television (TV),50492,0.0219613887723725,0.0237052409685354,-0.024500883525957,0.0684236610707019,0.354228025624375
CR2,Complement receptor type 2,Physical activities,X1080.Time spent using computer,45185,-0.040271331862625,0.0250697096459637,-0.0894079627687139,0.00886529904346387,0.108206971068936
CR2,Complement receptor type 2,Physical activities,X1090.Time spent driving,42579,-0.0822933853428822,0.0275600131560796,-0.136311011128798,-0.0282757595569662,0.00283057570908369
CR2,Complement receptor type 2,Lifestyle factors,X1160.Sleep duration,52027,-0.010342105509268,0.0214908380926795,-0.0524641481709198,0.0317799371523838,0.630354562039911
CR2,Complement receptor type 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34123,0.0265314385938452,0.0171088022856615,-0.00700181388605134,0.0600646910737418,0.12099484103359
CR2,Complement receptor type 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34123,-0.00258667851101579,0.0153698972648628,-0.0327116771501468,0.0275383201281152,0.866354641972236
CR2,Complement receptor type 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34123,0.0359036693292486,0.0183119538946497,1.22396957351889e-05,0.0717950989627621,0.0499463787426669
CR2,Complement receptor type 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34123,-0.0304421277231008,0.0187537038980523,-0.0671993873632833,0.00631513191708175,0.104566538959731
CR2,Complement receptor type 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34123,-0.0108401807273187,0.0189670629171472,-0.0480156240449273,0.0263352625902898,0.567656025521884
CR2,Complement receptor type 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34123,0.0795494779730454,0.0361509119837812,0.00869369048483426,0.150405265461256,0.0277961791903405
CR2,Complement receptor type 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34123,0.00308078323813511,0.036062560216431,-0.0676018347860696,0.0737634012623398,0.931922222206094
CR2,Complement receptor type 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34123,-0.00266667837582947,0.0279413445221848,-0.0574317136393117,0.0520983568876527,0.923968560842033
CR2,Complement receptor type 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34123,0.00767764300817268,0.0200868143259394,-0.0316925130706685,0.0470477990870139,0.702304340638038
CR2,Complement receptor type 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34123,0.00329169222530945,0.013815073816096,-0.0237858524542387,0.0303692369048576,0.811678162552003
CR2,Complement receptor type 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34123,0.0446963516364276,0.0192788896719223,0.00690972787945986,0.0824829753933953,0.0204478506024797
CR2,Complement receptor type 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34123,0.00740840440888252,0.011769233330581,-0.0156592929190562,0.0304761017368212,0.529054876462539
CR2,Complement receptor type 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34123,0.00517748086403563,0.0146937114756922,-0.023622193628321,0.0339771553563923,0.724575735010733
CR2,Complement receptor type 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34123,-0.0150851070193076,0.02096160420892,-0.0561698512687909,0.0259996372301756,0.47175530724369
CR2,Complement receptor type 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34123,-0.00748049319764091,0.0199816090655914,-0.0466444469662,0.0316834605709182,0.708138078422575
CR2,Complement receptor type 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34123,0.00570003422081593,0.027983906614753,-0.0491484227441,0.0605484911857319,0.83860025840474
CR2,Complement receptor type 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34123,-0.0154562796278449,0.025865912264129,-0.0661534676655377,0.0352409084098479,0.550151548745409
CR2,Complement receptor type 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34123,0.00780278284516165,0.0156884298008209,-0.0229465395644473,0.0385521052547706,0.618947170892231
CR2,Complement receptor type 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34123,0.0113415701228001,0.0146443553015101,-0.0173613662681598,0.04004450651376,0.438673600653443
CR2,Complement receptor type 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34123,0.012786550911793,0.0195303114489269,-0.0254928595281038,0.0510659613516897,0.512674648612225
CR2,Complement receptor type 2,Health and medical history,X120040.Fatigue severity over the past week,34129,0.0498756751215851,0.0379106668360487,-0.0244292318770704,0.124180582120241,0.188335948273723
CR2,Complement receptor type 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34126,0.0463860316718632,0.0377248412807862,-0.0275546572384778,0.120326720582204,0.218881141481967
CR2,Complement receptor type 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34126,0.0100963571181669,0.0406508753713036,-0.0695793586095882,0.089772072845922,0.803855334301611
CR2,Complement receptor type 2,Health and medical history,X120098.Mobility problems today,34133,-0.0170718456284043,0.0449978390908555,-0.105267610246481,0.0711239189896725,0.704404694124974
CR2,Complement receptor type 2,Health and medical history,X120099.Self-care problems today,34133,0.0237832083947314,0.0711891222052934,-0.115747471127644,0.163313887917106,0.738322758094172
CR2,Complement receptor type 2,Health and medical history,X120100.Problems doing usual activities,34133,0.0132764786754023,0.0424681009253724,-0.0699609991383276,0.0965139564891323,0.754574310689653
CR2,Complement receptor type 2,Health and medical history,X120101.Pain or discomfort today,34133,0.0154460074955515,0.038096280849867,-0.0592227029701879,0.0901147179612908,0.68515822636651
CR2,Complement receptor type 2,Health and medical history,X120102.Anxiety or depression today,34133,-0.0171672456197449,0.044643713928902,-0.104668924920393,0.0703344336809029,0.700587502931552
CR2,Complement receptor type 2,Health and medical history,X120103.Scale to indicate how health is today,34094,-0.00150374262310845,0.00508772067479642,-0.0114756751457094,0.00846818989949253,0.767570102255944
CR2,Complement receptor type 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34108,-0.0295827229424515,0.045955764823434,-0.119656021996382,0.0604905761114792,0.519771208806855
CR2,Complement receptor type 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34084,-0.0826457409302275,0.0463609148652841,-0.173513134066184,0.00822165220572925,0.0746731859576349
CR2,Complement receptor type 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34115,-0.0549756804409506,0.0375141799772886,-0.128503473196436,0.0185521123145351,0.142826909008188
CR2,Complement receptor type 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34109,0.0134325869402271,0.0385768410618646,-0.0621780215410276,0.0890431954214817,0.72769503146288
CR2,Complement receptor type 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34118,0.0260119649517418,0.0467676713815504,-0.065652670956097,0.117676600859581,0.57809014239708
CR2,Complement receptor type 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34088,-0.0244521301012967,0.0485373787175332,-0.119585392387662,0.0706811321850682,0.614427945085464
CR2,Complement receptor type 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34113,-0.0424338790275105,0.0499776398973062,-0.140390053226231,0.0555222951712097,0.395870461746525
CR2,Complement receptor type 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34104,-0.012333226637369,0.0733498464202515,-0.156098925621062,0.131432472346324,0.866474697852655
CR2,Complement receptor type 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34066,-0.161311426005816,0.0984599102186543,-0.354292850034378,0.0316699980227465,0.101382212035304
CR2,Complement receptor type 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31736,0.0189506564497615,0.049721687276637,-0.078503850612447,0.11640516351197,0.703114477578274
CR2,Complement receptor type 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49670,-0.166493478837883,0.052401227030653,-0.269199883817963,-0.063787073857803,0.00148841597565478
CR2,Complement receptor type 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47814,-0.0831544467247658,0.0339701310492484,-0.149735903581293,-0.016572989868239,0.014377676216531
CR2,Complement receptor type 2,Diet and food preferences,X1289.Cooked vegetable intake,51490,-0.0599904422346757,0.0223880846362738,-0.103871088121772,-0.016109796347579,0.00737613998063664
CR2,Complement receptor type 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50983,-0.0384702940500951,0.0242229140424844,-0.0859472055733645,0.00900661747317419,0.112258058922173
CR2,Complement receptor type 2,Diet and food preferences,X1309.Fresh fruit intake,51531,0.0832347445816606,0.0232263772997302,0.0377110450741894,0.128758444089132,0.000339446653761311
CR2,Complement receptor type 2,Diet and food preferences,X1319.Dried fruit intake,49759,0.0705944902259221,0.0234286562744477,0.0246743239280047,0.11651465652384,0.00258790966153536
CR2,Complement receptor type 2,Health and medical history,X134.Number of self-reported cancers,52315,-0.0983113821754309,0.0384223716496152,-0.173619230608677,-0.0230035337421852,0.0105116264633778
CR2,Complement receptor type 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52315,0.0935321584769274,0.0223215803520791,0.0497818609868524,0.137282455967002,2.7955166928346e-05
CR2,Complement receptor type 2,Health and medical history,"X136.Number of operations, self-reported",52315,0.0856888812347091,0.022503679475828,0.0415816694620861,0.129796093007332,0.000140524863852647
CR2,Complement receptor type 2,Health and medical history,X137.Number of treatments or medications taken,52315,0.0297621415262094,0.0218792857356676,-0.0131212585156991,0.0726455415681178,0.17374964029099
CR2,Complement receptor type 2,Diet and food preferences,X1438.Bread intake,51370,0.0166918697647201,0.00343337122417229,0.00996246216534238,0.0234212773640978,1.17063535417874e-06
CR2,Complement receptor type 2,Diet and food preferences,X1458.Cereal intake,50924,0.153252815539493,0.0221847458671367,0.109770713639905,0.196734917439081,5.02561124336108e-12
CR2,Complement receptor type 2,Diet and food preferences,X1488.Tea intake,51390,0.00607981892518809,0.00319724000477628,-0.000186771484173421,0.0123464093345496,0.0572362816159921
CR2,Complement receptor type 2,Diet and food preferences,X1498.Coffee intake,50097,-0.0683037462670839,0.0224939359638092,-0.11239186075615,-0.0242156317780177,0.00239550242069327
CR2,Complement receptor type 2,Diet and food preferences,X1528.Water intake,50571,-0.0250430538277439,0.0228317318362299,-0.0697932482267545,0.0197071405712667,0.272715764850175
CR2,Complement receptor type 2,Lifestyle factors,X1568.Average weekly red wine intake,41459,-0.0246329268465218,0.0274716380241188,-0.0784773373737947,0.0292114836807511,0.369909024363724
CR2,Complement receptor type 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41458,-0.146148762456345,0.0276698989600747,-0.200381764418091,-0.0919157604945984,1.29447634569532e-07
CR2,Complement receptor type 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,41485,-0.0591528167040565,0.0350583590436976,-0.127867200429704,0.00956156702159089,0.0915703102785527
CR2,Complement receptor type 2,Lifestyle factors,X1598.Average weekly spirits intake,41413,-0.0807169897526979,0.0308806522129676,-0.141243068090114,-0.0201909114152814,0.00896108409777773
CR2,Complement receptor type 2,Lifestyle factors,X1608.Average weekly fortified wine intake,41490,0.035827403329758,0.0468892054396026,-0.0560754393318632,0.127730245991379,0.444826348871407
CR2,Complement receptor type 2,Lifestyle factors,X1737.Childhood sunburn occasions,45678,-0.047238771086672,0.0267797629974093,-0.0997271065615942,0.00524956438825013,0.0777509574014397
CR2,Complement receptor type 2,Health and medical history,X1807.Father's age at death,44794,0.00286667664166982,0.00370796295465659,-0.0044009307494571,0.0101342840327967,0.439464127788214
CR2,Complement receptor type 2,Health and medical history,X1845.Mother's age,35300,-0.0189410705229178,0.0083333195393075,-0.0352743768199605,-0.00260776422587514,0.0230497341795318
CR2,Complement receptor type 2,Health and medical history,X1873.Number of full brothers,51802,-0.00938755309542469,0.0215720286914466,-0.05166872933066,0.0328936231398106,0.663440674808125
CR2,Complement receptor type 2,Health and medical history,X1883.Number of full sisters,51808,-0.0535940951057711,0.0216206163415549,-0.0959705031352187,-0.0112176870763235,0.0131869439834778
CR2,Complement receptor type 2,Physical measures,X20015.Sitting height,52121,0.0199515554234154,0.00423438775914318,0.0116521554154947,0.028250955431336,2.46740309953214e-06
CR2,Complement receptor type 2,Cognitive function,X20016.Fluid intelligence score,33372,-0.0489141741135873,0.0355664074807743,-0.118624332775905,0.0207959845487303,0.169075707711606
CR2,Complement receptor type 2,Cognitive function,X20018.Prospective memory result,33706,-0.00411749193063208,0.0466215292816299,-0.0954956893226266,0.0872607054613624,0.929626326495396
CR2,Complement receptor type 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33245,0.00935498593152094,0.00591840718876048,-0.00224509215844961,0.0209550640214915,0.113991905027858
CR2,Complement receptor type 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33216,0.0121359063350717,0.00589096632680643,0.000589612334531095,0.0236822003356123,0.0394196297860177
CR2,Complement receptor type 2,Cognitive function,X20023.Mean time to correctly identify matches,52000,0.00237827686022772,0.00346809834748593,-0.0044191959008447,0.00917574962130015,0.49287137368473
CR2,Complement receptor type 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49065,0.00323744740301192,0.00708562626029294,-0.0106503800671622,0.0171252748731861,0.647744443986296
CR2,Complement receptor type 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48635,-0.00507317556925086,0.0153828545396651,-0.0352235704669944,0.0250772193284927,0.741558357950082
CR2,Complement receptor type 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48603,-0.00331227767632771,0.0209379616245024,-0.0443506824603525,0.037726127107697,0.874304585217017
CR2,Complement receptor type 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48619,-0.0136757105753869,0.0169022621420471,-0.0468041443737992,0.0194527232230255,0.418462521760092
CR2,Complement receptor type 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48623,-0.00899637137073901,0.0126520209533818,-0.0337943324393674,0.0158015896978894,0.477052675510702
CR2,Complement receptor type 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48790,0.0101386429124824,0.00920605398721786,-0.00790522290246461,0.0281825087274294,0.270776262603997
CR2,Complement receptor type 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48721,-0.00685259488728944,0.0115736029775601,-0.0295368567233073,0.0158316669487284,0.553796978375093
CR2,Complement receptor type 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48631,-0.0194721410164605,0.0147699095066358,-0.0484211636494667,0.00947688161654561,0.187393769547436
CR2,Complement receptor type 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48781,-0.0151855309192916,0.0104009043089257,-0.0355713033647861,0.00520024152620276,0.144297420615127
CR2,Complement receptor type 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48841,0.00449045373211346,0.00788429032130092,-0.0109627552976363,0.0199436627618633,0.56899196522633
CR2,Complement receptor type 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48710,0.0323328473981246,0.0109933643072625,0.0107858533558902,0.0538798414403591,0.00327332509637922
CR2,Complement receptor type 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50455,0.0212981363633729,0.00787817106070193,0.00585692108439713,0.0367393516423487,0.00686711277951178
CR2,Complement receptor type 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50323,-0.00136706920648676,0.0114931091319471,-0.023893563105103,0.0211594246921295,0.905318382380801
CR2,Complement receptor type 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,50255,-0.00620814689811547,0.0246012901573813,-0.0544266756065828,0.0420103818103518,0.800772198042698
CR2,Complement receptor type 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,50294,0.0171271125077084,0.0124186178293643,-0.00721337843784554,0.0414676034532623,0.167861048420445
CR2,Complement receptor type 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50389,-0.0110931530267972,0.00907125018361125,-0.0288728033866752,0.00668649733308084,0.221381862090128
CR2,Complement receptor type 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50279,0.0145607946542989,0.0167578852577587,-0.0182846604509081,0.047406249759506,0.384914207492841
CR2,Complement receptor type 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50275,-0.0314665003110547,0.0148316601316995,-0.0605365541691857,-0.00239644645292364,0.0338828219935337
CR2,Complement receptor type 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50303,-0.00852208849155317,0.0118490209658972,-0.0317461695847117,0.0147019926016054,0.472010027113817
CR2,Complement receptor type 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50321,-0.0128699016659038,0.013190972040192,-0.0387242068646802,0.0129844035328726,0.329242183313739
CR2,Complement receptor type 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50481,0.0156513979860609,0.00683938347620427,0.00224620637270056,0.0290565895994213,0.0221209133259238
CR2,Complement receptor type 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50336,0.0138495227007497,0.0107813578082613,-0.00728193860344251,0.0349809840049418,0.198950389999158
CR2,Complement receptor type 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46813,0.0088946377092746,0.011203583524244,-0.0130643859982437,0.0308536614167929,0.427256215290818
CR2,Complement receptor type 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46667,0.036339357080498,0.0440704875390814,-0.0500387984961016,0.122717512657098,0.409622612851344
CR2,Complement receptor type 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46664,0.0342795381110526,0.0456837738469188,-0.0552606586289082,0.123819734851013,0.453042415838831
CR2,Complement receptor type 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46728,-0.0141319870610663,0.0123821092785689,-0.0384009212470614,0.0101369471249288,0.25374777127642
CR2,Complement receptor type 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46679,-0.00888602797729193,0.0261610920490439,-0.0601617683934179,0.0423897124388341,0.734111437130747
CR2,Complement receptor type 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46691,0.00298196420038585,0.0191643950805028,-0.0345802501573997,0.0405441785581714,0.87635038188051
CR2,Complement receptor type 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46674,-0.0620442610896588,0.0231489910860021,-0.107416283618223,-0.0166722385610947,0.00736292503486089
CR2,Complement receptor type 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46672,-0.00880416754354487,0.0225001609468674,-0.052904482999405,0.0352961479123153,0.695584028055412
CR2,Complement receptor type 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46690,-0.000831368504361247,0.0164949701130532,-0.0331615099259456,0.0314987729172231,0.959803025715257
CR2,Complement receptor type 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46693,-0.0144622252648702,0.0199452488391297,-0.0535549129895645,0.0246304624598241,0.468400609388069
CR2,Complement receptor type 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46883,0.0127200010890411,0.00826206681056463,-0.00347364985966554,0.0289136520377478,0.123680167909823
CR2,Complement receptor type 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46764,0.0176418185080133,0.0118700897603387,-0.00562355742225056,0.0409071944382771,0.137229417059308
CR2,Complement receptor type 2,Mental health,X20127.Neuroticism score,46355,-0.00871580981941891,0.0226177000903046,-0.053046501996416,0.0356148823575781,0.699979275300939
CR2,Complement receptor type 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33372,0.0037292876781109,0.0361253234204803,-0.0670763462260305,0.0745349215822523,0.917781204332942
CR2,Complement receptor type 2,Lifestyle factors,X20161.Pack years of smoking,31870,-0.0073850717175071,0.00702554716958274,-0.0211551441698893,0.00638500073487506,0.293212971890826
CR2,Complement receptor type 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31870,-0.00719709745187991,0.00693316439541033,-0.0207860996668842,0.00639190476312434,0.299272137768403
CR2,Complement receptor type 2,Cognitive function,X20191.Fluid intelligence score,31519,0.0235124838243711,0.0408062092319203,-0.0564676862701927,0.103492653918935,0.564499278988462
CR2,Complement receptor type 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31519,-0.0145512357575473,0.0417315193278005,-0.0963450136400363,0.0672425421249417,0.727334755302603
CR2,Complement receptor type 2,Cognitive function,X20240.Maximum digits remembered correctly,30759,0.00309639395077973,0.0437811837064517,-0.0827147261138656,0.0889075140154251,0.943619418919938
CR2,Complement receptor type 2,Physical measures,X20255.Spirometry QC measure,45868,0.0341802743490093,0.0300239225673064,-0.0246666138829112,0.0930271625809298,0.254951757989869
CR2,Complement receptor type 2,Eye measures,X20261.avMSE,30493,-0.00123023403926675,0.00674116650758095,-0.0144429203941254,0.0119824523155919,0.855199836121643
CR2,Complement receptor type 2,Eye measures,X20262.Myopia diagnosis,30493,0.0226461888559675,0.0540250033715894,-0.0832428177523477,0.128535195464283,0.675099657272229
CR2,Complement receptor type 2,NMR metabolomics,X20280.Glucose-lactate,40358,0.0114154858924776,0.00441797356302706,0.00275625770894461,0.0200747140760107,0.00977858725279625
CR2,Complement receptor type 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,40396,0.00751874844778641,0.00423315768440454,-0.000778240613646498,0.0158157375092193,0.0757262734853787
CR2,Complement receptor type 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,33213,-0.0422377237574872,0.0202177703312301,-0.0818645536066983,-0.00261089390827614,0.0367240333024379
CR2,Complement receptor type 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,33210,0.0138077167569468,0.0378164214444862,-0.0603124692742462,0.0879279027881398,0.715026998189643
CR2,Complement receptor type 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),33209,-0.0590557345022904,0.0467305720619306,-0.150647655743674,0.0325361867390936,0.206353612001085
CR2,Complement receptor type 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),33209,-0.0378948029002669,0.0189441927785903,-0.0750254207463039,-0.000764185054229878,0.0454945190993917
CR2,Complement receptor type 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),33209,-0.0864838274604063,0.0373274847260704,-0.159645697523504,-0.0133219573973084,0.0205324579426294
CR2,Complement receptor type 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,33216,-0.0938682944283026,0.0465126152697071,-0.185033020356929,-0.00270356849967665,0.0436086024256049
CR2,Complement receptor type 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,33216,-0.043690528517013,0.0307013159196903,-0.103865107719606,0.01648405068558,0.154747617436682
CR2,Complement receptor type 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,33216,-0.0326207045288186,0.0334777592711353,-0.0982371127002437,0.0329957036426066,0.329885220158503
CR2,Complement receptor type 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,33216,-0.0797055743624448,0.0550118984341177,-0.187528895293316,0.0281177465684259,0.147407205019522
CR2,Complement receptor type 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,33216,0.0206923924277797,0.0665663383099162,-0.109777630659656,0.151162415515215,0.755919238072905
CR2,Complement receptor type 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,33216,-0.0343075257051138,0.0349606430924928,-0.1028303861664,0.0342153347561722,0.326462792772581
CR2,Complement receptor type 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,33216,0.0594549125178755,0.0671238238364743,-0.072107782201614,0.191017607237365,0.375776676555674
CR2,Complement receptor type 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,33216,0.000432252684047315,0.0459709505140815,-0.0896708103235523,0.090535315691647,0.992498027152244
CR2,Complement receptor type 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),33215,-0.0666731499331892,0.0541427647744879,-0.172792968891185,0.039446669024807,0.21819426479599
CR2,Complement receptor type 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),33215,-0.0466655934386855,0.0257016171658518,-0.0970407630837549,0.00370957620638398,0.0694555395391483
CR2,Complement receptor type 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),33215,-0.0466771280155659,0.0415143782477125,-0.128045309381082,0.0346910533499506,0.260890910097856
CR2,Complement receptor type 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,33217,0.0478155946708582,0.0614799591851735,-0.0726851253320818,0.168316314673798,0.436741655610649
CR2,Complement receptor type 2,Diet and food preferences,X20600.Liking for adding salt to foods,35063,-0.0716631938504363,0.0332664643844577,-0.136865464043973,-0.00646092365689924,0.0312455947232331
CR2,Complement receptor type 2,Diet and food preferences,X20601.Liking for aniseed,35063,-0.0700196861908442,0.0334625164902528,-0.13560621851174,-0.00443315386994883,0.0364192104965178
CR2,Complement receptor type 2,Diet and food preferences,X20602.Liking for apple juice,35063,0.0418121595716534,0.0334499623186169,-0.0237497665728358,0.107374085716143,0.211330341260713
CR2,Complement receptor type 2,Diet and food preferences,X20603.Liking for apples,35063,0.0826326161209332,0.0343821321105355,0.0152436371842835,0.150021595057583,0.016262282974042
CR2,Complement receptor type 2,Diet and food preferences,X20604.Liking for asparagus,35063,0.0300177715683574,0.0345692442677626,-0.0377379471964573,0.0977734903331721,0.385229247143736
CR2,Complement receptor type 2,Diet and food preferences,X20605.Liking for aubergine,35063,0.0184279909109694,0.0335297466120052,-0.0472903124485608,0.0841462942704996,0.582604472336813
CR2,Complement receptor type 2,Diet and food preferences,X20606.Liking for avocados,35063,-0.0458733095942807,0.034506314819948,-0.113505686641379,0.0217590674528174,0.183738768446918
CR2,Complement receptor type 2,Diet and food preferences,X20607.Liking for bacon,35063,-0.103665096769298,0.0339428787855285,-0.170193139188934,-0.0371370543496618,0.00226293515492921
CR2,Complement receptor type 2,Diet and food preferences,X20608.Liking for baked or steamed fish,35063,-0.00466156525321136,0.0344206399675138,-0.0721260195895384,0.0628028890831157,0.892274982824971
CR2,Complement receptor type 2,Diet and food preferences,X20609.Liking for bananas,35063,0.024533940465439,0.0350732508463064,-0.0442096311933216,0.0932775121241996,0.484251370393311
CR2,Complement receptor type 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35063,-0.0954371831216559,0.0336836651432584,-0.161457166802442,-0.0294171994408695,0.00461517260119
CR2,Complement receptor type 2,Diet and food preferences,X20611.Liking for beef steak,35063,-0.136407233841925,0.0337436371576762,-0.202544762670971,-0.07026970501288,5.32677548204259e-05
CR2,Complement receptor type 2,Diet and food preferences,X20612.Liking for beetroot,35063,0.0558692962267265,0.0344053485135723,-0.0115651868598752,0.123303779313328,0.104436492935212
CR2,Complement receptor type 2,Diet and food preferences,X20613.Liking for bell pepper,35063,-0.0206466322651408,0.0339313031615431,-0.0871519864617652,0.0458587219314835,0.54287999598072
CR2,Complement receptor type 2,Diet and food preferences,X20614.Liking for bicycling,35063,-0.0181373231189804,0.033638293574585,-0.084068378525167,0.0477937322872062,0.589769305053668
CR2,Complement receptor type 2,Diet and food preferences,X20615.Liking for biscuits,35063,0.0183413488956836,0.0337782172983342,-0.0478639570090514,0.0845466548004186,0.587145764853678
CR2,Complement receptor type 2,Diet and food preferences,X20616.Liking for bitter foods,35063,-0.0526498181595357,0.0337184826886571,-0.118738044229304,0.0134384079102323,0.118446806709942
CR2,Complement receptor type 2,Diet and food preferences,X20617.Liking for bitter or ale,35063,-0.131572388754745,0.0350341350207962,-0.200239293395506,-0.0629054841139849,0.000173887837892047
CR2,Complement receptor type 2,Diet and food preferences,X20618.Liking for black olives,35063,-0.0545425549416315,0.0341371616700504,-0.12145139181493,0.0123662819316674,0.110129047731616
CR2,Complement receptor type 2,Diet and food preferences,X20619.Liking for black pepper,35063,-0.0391941983729283,0.034068601346703,-0.105968657012466,0.0275802602666097,0.24998481467969
CR2,Complement receptor type 2,Diet and food preferences,X20620.Liking for blue cheese,35063,-0.110118694839694,0.0336360613111948,-0.176045375009636,-0.044192014669752,0.00106440967998727
CR2,Complement receptor type 2,Diet and food preferences,X20621.Liking for bolognese sauce,35063,-0.0780610593040707,0.0338144164168149,-0.144337315481028,-0.0117848031271135,0.0209896987702775
CR2,Complement receptor type 2,Diet and food preferences,X20622.Liking for broad beans,35063,0.0292364592671663,0.0336758525741775,-0.0367682117782217,0.0952411303125542,0.385319392308813
CR2,Complement receptor type 2,Diet and food preferences,X20623.Liking for broccoli,35063,0.0442029762036412,0.0352530445857925,-0.0248929911845121,0.113298943591795,0.209914420265367
CR2,Complement receptor type 2,Diet and food preferences,X20624.Liking for brown rice,35063,0.0247011349483252,0.0338024441385767,-0.0415516555632851,0.0909539254599355,0.46494803709522
CR2,Complement receptor type 2,Diet and food preferences,X20625.Liking for brussel sprouts,35063,0.0588128411629936,0.0340212674432029,-0.00786884302568413,0.125494525351671,0.083890460919551
CR2,Complement receptor type 2,Diet and food preferences,X20626.Liking for burgers (meat),35063,-0.113695236622976,0.0335687495194152,-0.179489985681029,-0.0479004875649217,0.000709345185135264
CR2,Complement receptor type 2,Diet and food preferences,X20627.Liking for burn of spicy foods,35063,-0.113870970009551,0.03389343217448,-0.180302097071531,-0.0474398429475699,0.0007830899046459
CR2,Complement receptor type 2,Diet and food preferences,X20628.Liking for butter on bread,35063,-0.0651334924440737,0.034252845369084,-0.132269069367478,0.00200208447933094,0.0572571138592423
CR2,Complement receptor type 2,Diet and food preferences,X20629.Liking for butternut squash,35063,0.067120143124134,0.0338937430078523,0.000688406828743507,0.133551879419525,0.0476944328767941
CR2,Complement receptor type 2,Diet and food preferences,X20630.Liking for cabbage,35063,0.0473320851622017,0.0340226861191131,-0.0193523796312599,0.114016549955663,0.164196436793713
CR2,Complement receptor type 2,Diet and food preferences,X20631.Liking for cake,35063,0.0242967595789953,0.0338614391050408,-0.0420716610668846,0.0906651802248752,0.473060005227037
CR2,Complement receptor type 2,Diet and food preferences,X20632.Liking for cake icing,35063,0.000805146910895263,0.0336054492755823,-0.065061533669246,0.0666718274910366,0.980885907029551
CR2,Complement receptor type 2,Diet and food preferences,X20633.Liking for capers,35063,-0.0876268720597832,0.0332705698262271,-0.152837188919188,-0.022416555200378,0.00845664567278658
CR2,Complement receptor type 2,Diet and food preferences,X20634.Liking for cauliflower,35063,0.0222267503771904,0.0345105508317432,-0.0454139292530263,0.0898674300074071,0.519552620539769
CR2,Complement receptor type 2,Diet and food preferences,X20635.Liking for cereal or granola bar,35063,0.00719212760774234,0.033404522795398,-0.0582807370712377,0.0726649922867224,0.829534447249877
CR2,Complement receptor type 2,Diet and food preferences,X20636.Liking for cheesecake,35063,-0.0487650503539584,0.0335721019930868,-0.114566370260409,0.0170362695524917,0.146379211462938
CR2,Complement receptor type 2,Diet and food preferences,X20637.Liking for cherries,35063,0.00260271271334867,0.0366969232209556,-0.0693232567997243,0.0745286822264216,0.943459143373776
CR2,Complement receptor type 2,Diet and food preferences,X20638.Liking for chicken,35063,-0.0220103329347533,0.0356287012402022,-0.0918425873655496,0.0478219214960429,0.536740412383474
CR2,Complement receptor type 2,Diet and food preferences,X20639.Liking for chilli pepper,35063,-0.0812749974405153,0.0336832480758343,-0.14729416366915,-0.0152558312118802,0.0158421305130207
CR2,Complement receptor type 2,Diet and food preferences,X20640.Liking for chips or french fries,35063,-0.0351693190552863,0.0336319296080899,-0.101087901087142,0.0307492629765698,0.295717769573283
CR2,Complement receptor type 2,Diet and food preferences,X20641.Liking for cigarette smoking,35063,0.0545429004883623,0.0566342143150694,-0.0564601595691737,0.165545960545898,0.335532697586046
CR2,Complement receptor type 2,Diet and food preferences,X20642.Liking for cod,35063,-0.00265836936229005,0.0346853390529431,-0.0706416339060585,0.0653248951814784,0.938909434261218
CR2,Complement receptor type 2,Diet and food preferences,X20643.Liking for coffee with sugar,35063,-0.0121823500374446,0.0383215946894741,-0.0872926756288139,0.0629279755539247,0.750568734413296
CR2,Complement receptor type 2,Diet and food preferences,X20644.Liking for coffee without sugar,35063,-0.0432257271745965,0.0343867612814798,-0.110623779286297,0.0241723249371039,0.20876481361342
CR2,Complement receptor type 2,Diet and food preferences,X20645.Liking for coriander,35063,-0.0705312978517925,0.0337074312655359,-0.136597863132243,-0.00446473257134217,0.036421512028937
CR2,Complement receptor type 2,Diet and food preferences,X20646.Liking for corn flakes,35063,0.0375903478276777,0.033461054564063,-0.0279933191178856,0.103174014773241,0.261290560719719
CR2,Complement receptor type 2,Diet and food preferences,X20647.Liking for cream,35063,-0.0381708744543559,0.0336547511559227,-0.104134186719964,0.0277924378112525,0.256740598211316
CR2,Complement receptor type 2,Diet and food preferences,X20648.Liking for croissant,35063,0.0028984210129054,0.0336200220119249,-0.0629968221304675,0.0687936641562783,0.931300189320618
CR2,Complement receptor type 2,Diet and food preferences,X20649.Liking for cucumber,35063,0.0241156072472203,0.0342829370989104,-0.0430789494666441,0.0913101639610848,0.481803975440073
CR2,Complement receptor type 2,Diet and food preferences,X20650.Liking for curry,35063,-0.0639708486488523,0.0337846710457364,-0.130188803898496,0.00224710660079101,0.058320285063446
CR2,Complement receptor type 2,Diet and food preferences,X20651.Liking for dairy products,35063,0.0076065404979314,0.0342976586082066,-0.0596168703741536,0.0748299513700164,0.82448928995314
CR2,Complement receptor type 2,Diet and food preferences,X20652.Liking for dark chocolate,35063,-0.0346663234172655,0.0340111930648052,-0.101328261824284,0.0319956149897527,0.308101762871572
CR2,Complement receptor type 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35063,-0.0377107076527098,0.0352382928024643,-0.10677776154554,0.0313563462401202,0.284570429221096
CR2,Complement receptor type 2,Diet and food preferences,X20654.Liking for dried fruit,35063,0.0381672967112828,0.0337240432922405,-0.0279318281415087,0.104266421564074,0.25776377086494
CR2,Complement receptor type 2,Diet and food preferences,X20655.Liking for eggs,35063,-0.0646089455494849,0.0349545503691456,-0.13311986427301,0.00390197317404051,0.0645766502345957
CR2,Complement receptor type 2,Diet and food preferences,X20656.Liking for exercising alone,35063,-0.0299314450524917,0.0334251424180669,-0.0954447241919027,0.0355818340869194,0.370552504630657
CR2,Complement receptor type 2,Diet and food preferences,X20657.Liking for exercising with others,35063,0.037511287186735,0.0335027490180014,-0.0281541008885479,0.103176675262018,0.262889140721196
CR2,Complement receptor type 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35063,0.00778665545263751,0.0343373987345101,-0.0595146460670022,0.0750879569722773,0.820607790223086
CR2,Complement receptor type 2,Diet and food preferences,X20659.Liking for fatty foods,35063,-0.0376319315304857,0.0336244039570657,-0.103535763286334,0.028271900225363,0.263086540748503
CR2,Complement receptor type 2,Diet and food preferences,X20660.Liking for fresh tomatoes,35063,0.0092185558302989,0.0372034312876768,-0.0637001694935477,0.0821372811541455,0.80430340506033
CR2,Complement receptor type 2,Diet and food preferences,X20661.Liking for fried chicken,35063,-0.0304108541465838,0.0334248464612127,-0.0959235532105606,0.0351018449173931,0.362934020080449
CR2,Complement receptor type 2,Diet and food preferences,X20662.Liking for fried or battered fish,35063,-0.0691271405813247,0.0335519054990099,-0.134888875359384,-0.00336540580326532,0.0393937895334844
CR2,Complement receptor type 2,Diet and food preferences,X20663.Liking for fruit,35063,0.0969274616793873,0.0391192966357162,0.0202536402733836,0.173601283085391,0.0132371895962817
CR2,Complement receptor type 2,Diet and food preferences,X20664.Liking for garlic,35063,-0.0584836688182802,0.0341348164489472,-0.125387909058217,0.00842057142165642,0.0866839694637244
CR2,Complement receptor type 2,Diet and food preferences,X20665.Liking for gherkins,35063,-0.0782175408563723,0.0336316639607054,-0.144135602219355,-0.0122994794933897,0.0200527229602824
CR2,Complement receptor type 2,Diet and food preferences,X20666.Liking for globe artichoke,35063,0.00670829963634488,0.0335940422392625,-0.0591360231526095,0.0725526224252993,0.841729068588824
CR2,Complement receptor type 2,Diet and food preferences,X20667.Liking for goat's cheese,35063,-0.026393218966845,0.0336353519604146,-0.0923185088092575,0.0395320708755675,0.432654716935687
CR2,Complement receptor type 2,Diet and food preferences,X20668.Liking for going to a cafe,35063,0.0464584721200733,0.0340158055553587,-0.0202125067684298,0.113129451008576,0.172033627295837
CR2,Complement receptor type 2,Diet and food preferences,X20669.Liking for going to the gym,35063,-0.0461096550753812,0.0336903387662948,-0.112142719057319,0.0199234089065566,0.171143526296712
CR2,Complement receptor type 2,Diet and food preferences,X20670.Liking for going to the pub,35063,-0.195520530021399,0.0335011447719192,-0.26118277377436,-0.129858286268437,5.49585275620167e-09
CR2,Complement receptor type 2,Diet and food preferences,X20671.Liking for grapefruit,35063,-0.0413848309576142,0.0336536972312267,-0.107346077530818,0.02457641561559,0.218826965386055
CR2,Complement receptor type 2,Diet and food preferences,X20672.Liking for green olives,35063,-0.0260019330162751,0.0340593003877849,-0.0927581617763336,0.0407542957437834,0.445223258323603
CR2,Complement receptor type 2,Diet and food preferences,X20673.Liking for haddock,35063,-0.0186822400571061,0.0344468467056156,-0.0861980596001127,0.0488335794859005,0.587588961434792
CR2,Complement receptor type 2,Diet and food preferences,X20674.Liking for ham,35063,-0.100283823552471,0.0337726932014395,-0.166478302227293,-0.03408934487765,0.00299073241436195
CR2,Complement receptor type 2,Diet and food preferences,X20675.Liking for hard cheese,35063,-0.0503754284446717,0.0348163689683776,-0.118615511622692,0.0178646547333485,0.147957521385892
CR2,Complement receptor type 2,Diet and food preferences,X20676.Liking for herring,35063,-0.058809478174546,0.0334290436592642,-0.124330403746704,0.00671144739761179,0.078566775214782
CR2,Complement receptor type 2,Diet and food preferences,X20677.Liking for honey,35063,0.00127677859382155,0.0337638886168644,-0.0649004430952328,0.0674540002828759,0.969835964024556
CR2,Complement receptor type 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35063,-0.0819277515376526,0.0335887527023607,-0.14776170683428,-0.0160937962410257,0.0147384526967861
CR2,Complement receptor type 2,Diet and food preferences,X20679.Liking for ice cream,35063,-0.016513324542085,0.0337338252081711,-0.0826316219501004,0.0496049728659304,0.624484934360114
CR2,Complement receptor type 2,Diet and food preferences,X20680.Liking for jam,35063,0.0402693800274167,0.0336035987052076,-0.0255936734347903,0.106132433489624,0.230801698586605
CR2,Complement receptor type 2,Diet and food preferences,X20681.Liking for kiwi fruit,35063,0.0513479147443729,0.0338571126650163,-0.015012026079059,0.117707855567805,0.129395895477848
CR2,Complement receptor type 2,Diet and food preferences,X20682.Liking for lager,35063,-0.177115341705752,0.0338419517282319,-0.243445567093086,-0.110785116318417,1.69414547756847e-07
CR2,Complement receptor type 2,Diet and food preferences,X20683.Liking for lamb,35063,-0.104050184145541,0.0337975530477094,-0.170293388119051,-0.03780698017203,0.00208485567346854
CR2,Complement receptor type 2,Diet and food preferences,X20684.Liking for lemons,35063,-0.0145126320340194,0.034139898424734,-0.0814268329464981,0.0524015688784592,0.670777503713918
CR2,Complement receptor type 2,Diet and food preferences,X20685.Liking for lentils or beans,35063,0.0459634313267821,0.033884478153663,-0.0204501458543973,0.112377008507962,0.174977120387113
CR2,Complement receptor type 2,Diet and food preferences,X20686.Liking for liver,35063,-0.0991432185181486,0.0338336570060426,-0.165457186249992,-0.032829250786305,0.00339342616265253
CR2,Complement receptor type 2,Diet and food preferences,X20687.Liking for mackerel,35063,-0.0303149369096897,0.0336777422788774,-0.0963233117762894,0.0356934379569099,0.368062183989243
CR2,Complement receptor type 2,Diet and food preferences,X20688.Liking for marzipan,35063,-0.0217310795495913,0.0336706962782803,-0.0877256442550207,0.0442634851558381,0.518681735874087
CR2,Complement receptor type 2,Diet and food preferences,X20689.Liking for mayonnaise,35063,-0.0380284011508018,0.0336161330930969,-0.103916022013272,0.0278592197116681,0.257973585545635
CR2,Complement receptor type 2,Diet and food preferences,X20690.Liking for melon,35063,0.0763855763348744,0.0353008630261742,0.00719588480357301,0.145575267866176,0.0304985508011957
CR2,Complement receptor type 2,Diet and food preferences,X20691.Liking for milk chocolate,35063,0.00350606719347152,0.0338603955470474,-0.0628603080787415,0.0698724424656845,0.91753256997578
CR2,Complement receptor type 2,Diet and food preferences,X20692.Liking for mushrooms,35063,-0.0136261492526784,0.0349845175890821,-0.0821958037272794,0.0549435052219226,0.696920906229861
CR2,Complement receptor type 2,Diet and food preferences,X20694.Liking for orange juice,35063,0.0220040948742417,0.0335230969152866,-0.04370117507972,0.0877093648282034,0.51158997665449
CR2,Complement receptor type 2,Diet and food preferences,X20695.Liking for oranges,35063,0.0494496075296515,0.03441527093265,-0.0180043234983425,0.116903538557645,0.150789917910891
CR2,Complement receptor type 2,Diet and food preferences,X20696.Liking for pasta,35063,0.0175256733908923,0.0339522339256335,-0.0490207051033494,0.0840720518851339,0.605735157959466
CR2,Complement receptor type 2,Diet and food preferences,X20697.Liking for pears,35063,0.0626292168568234,0.0345105421588452,-0.00501144577451325,0.13026987948816,0.0695851913919509
CR2,Complement receptor type 2,Diet and food preferences,X20698.Liking for pizza,35063,0.00822668873275803,0.0337539464276099,-0.0579310462653575,0.0743844237308735,0.807448338888222
CR2,Complement receptor type 2,Diet and food preferences,X20699.Liking for plain yogurt,35063,0.0295957350761105,0.0338373465473724,-0.0367254641567395,0.0959169343089604,0.381785795861672
CR2,Complement receptor type 2,Diet and food preferences,X20700.Liking for plums,35063,0.0776849306989179,0.0347623241043006,0.00955077545448868,0.145819085943347,0.0254548441876494
CR2,Complement receptor type 2,Diet and food preferences,X20701.Liking for pollock,35063,-0.0336282600878127,0.0335251278043592,-0.0993375105843567,0.0320809904087313,0.315846956738277
CR2,Complement receptor type 2,Diet and food preferences,X20702.Liking for pork chop,35063,-0.0746248404041766,0.0335614489893547,-0.140405280423312,-0.00884440038504127,0.0262011725928694
CR2,Complement receptor type 2,Diet and food preferences,X20703.Liking for porridge,35063,0.0990782234995914,0.0345085975233548,0.031441372353816,0.166715074645367,0.00409834172919472
CR2,Complement receptor type 2,Diet and food preferences,X20704.Liking for potato crisps,35063,0.016002171231241,0.0338699041430019,-0.0503828408890428,0.0823871833515247,0.636608288792018
CR2,Complement receptor type 2,Diet and food preferences,X20705.Liking for potatoes,35063,0.0408885315878316,0.0342379105311074,-0.0262177730531388,0.107994836228802,0.232407968325752
CR2,Complement receptor type 2,Diet and food preferences,X20706.Liking for prawns,35063,-0.0893708139688255,0.0343271581475397,-0.156652043938003,-0.0220895839996477,0.00924053982481546
CR2,Complement receptor type 2,Diet and food preferences,X20707.Liking for raw carrots,35063,0.0623816892167399,0.0341488867225337,-0.00455012875942611,0.129313507192906,0.0677645423305811
CR2,Complement receptor type 2,Diet and food preferences,X20708.Liking for red meat,35063,-0.119473152968227,0.0334958434593381,-0.18512500614853,-0.0538212997879244,0.000362952815475081
CR2,Complement receptor type 2,Diet and food preferences,X20709.Liking for red wine,35063,-0.141513723295117,0.0334588136214368,-0.207092997993133,-0.0759344485971007,2.36188778607445e-05
CR2,Complement receptor type 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35063,-0.0314401100968801,0.0355659503847232,-0.101149372850938,0.0382691526571775,0.37671914279666
CR2,Complement receptor type 2,Diet and food preferences,X20711.Liking for roast chicken,35063,-0.0118745421327832,0.0357372817143988,-0.0819196142930049,0.0581705300274385,0.739689518644429
CR2,Complement receptor type 2,Diet and food preferences,X20712.Liking for salad dressing,35063,-0.0518553228109724,0.0337020593433792,-0.117911359123996,0.0142007135020508,0.123922150386766
CR2,Complement receptor type 2,Diet and food preferences,X20713.Liking for salad leaves,35063,0.0605329058536128,0.0349997470894895,-0.00806659844178659,0.129132410149012,0.0837444444164011
CR2,Complement receptor type 2,Diet and food preferences,X20714.Liking for salami,35063,-0.109488847457842,0.0335763513437331,-0.175298496091559,-0.0436791988241249,0.00111413117462454
CR2,Complement receptor type 2,Diet and food preferences,X20715.Liking for salmon,35063,-0.00714473251362023,0.0360955595044051,-0.0778920291422542,0.0636025641150138,0.843096291189288
CR2,Complement receptor type 2,Diet and food preferences,X20716.Liking for salty foods,35063,-0.0458060463878269,0.0336406938831001,-0.111741806398703,0.0201297136230493,0.173344851538797
CR2,Complement receptor type 2,Diet and food preferences,X20717.Liking for salty pretzels,35063,-0.059920903044648,0.0336115451866673,-0.125799531610516,0.00595772552121995,0.0746559963785366
CR2,Complement receptor type 2,Diet and food preferences,X20718.Liking for sardines,35063,-0.0313896084401495,0.0335718231088437,-0.0971903817334831,0.0344111648531842,0.349810303216238
CR2,Complement receptor type 2,Diet and food preferences,X20719.Liking for sausages (meat),35063,-0.0795431500843529,0.0336513979471198,-0.145499890060708,-0.0135864101079981,0.018109443163634
CR2,Complement receptor type 2,Diet and food preferences,X20720.Liking for savoury biscuits,35063,-0.0215164496223459,0.033922864428909,-0.0880052639030076,0.0449723646583158,0.525914577171547
CR2,Complement receptor type 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35063,-0.107649712006391,0.0336194649865989,-0.173543863380125,-0.0417555606326575,0.00136877265117957
CR2,Complement receptor type 2,Diet and food preferences,X20722.Liking for skimmed milk,35063,-0.0207556743788698,0.0336013472047375,-0.0866143149001554,0.0451029661424158,0.536783981279303
CR2,Complement receptor type 2,Diet and food preferences,X20723.Liking for smoked fish,35063,-0.0258599195198405,0.0335212242556659,-0.0915615190609456,0.0398416800212646,0.440457952791035
CR2,Complement receptor type 2,Diet and food preferences,X20724.Liking for soft cheese,35063,-0.0605856905094129,0.0337589483466308,-0.126753229268809,0.00558184824998352,0.0727370424060044
CR2,Complement receptor type 2,Diet and food preferences,X20725.Liking for soy sauce,35063,-0.0803167270662871,0.0336614364175109,-0.146293142444608,-0.0143403116879658,0.0170494518081686
CR2,Complement receptor type 2,Diet and food preferences,X20726.Liking for soya milk,35063,0.0993263385261976,0.0339520358326177,0.0327803482942669,0.165872328758128,0.0034464354783965
CR2,Complement receptor type 2,Diet and food preferences,X20727.Liking for spicy foods,35063,-0.117845430955716,0.0336202282465198,-0.183741078318895,-0.0519497835925373,0.000458158866887329
CR2,Complement receptor type 2,Diet and food preferences,X20728.Liking for spinach,35063,0.0538895233039444,0.0341252276989497,-0.0129959229859971,0.120774969593886,0.114326986005955
CR2,Complement receptor type 2,Diet and food preferences,X20729.Liking for spirits,35063,-0.176587789388883,0.0335618106384354,-0.242368938240216,-0.110806640537549,1.45618389325331e-07
CR2,Complement receptor type 2,Diet and food preferences,X20730.Liking for strawberries,35063,0.0799067225896752,0.038493475349814,0.00445951090403977,0.155353934275311,0.037931770613747
CR2,Complement receptor type 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35063,-0.0261092587702306,0.0350436750178007,-0.09479486180512,0.0425763442646587,0.456258549291365
CR2,Complement receptor type 2,Diet and food preferences,X20732.Liking for sweet foods,35063,0.0375719826193968,0.0335929317629841,-0.028270163636052,0.103414128874846,0.263400596331866
CR2,Complement receptor type 2,Diet and food preferences,X20733.Liking for taking the stairs,35063,0.0248564644124695,0.0344893602801411,-0.0427426817366071,0.0924556105615461,0.471110315449366
CR2,Complement receptor type 2,Diet and food preferences,X20734.Liking for tea with sugar,35063,0.0078308998786822,0.0449159359883519,-0.0802043346584875,0.0958661344158519,0.861597122063614
CR2,Complement receptor type 2,Diet and food preferences,X20735.Liking for tea without sugar,35063,0.0507634286705096,0.0360106929205128,-0.0198175294536954,0.121344386794715,0.158664550394982
CR2,Complement receptor type 2,Diet and food preferences,X20736.Liking for tomato ketchup,35063,-0.0391564000208006,0.0334970384734416,-0.104810595428746,0.026497795387145,0.242449614785562
CR2,Complement receptor type 2,Diet and food preferences,X20737.Liking for tinned tuna,35063,0.000552194466142595,0.03394924461991,-0.0659883249888809,0.0670927139211661,0.98702305081188
CR2,Complement receptor type 2,Diet and food preferences,X20738.Liking for turnip (white),35063,0.00998258870644931,0.0333387605587025,-0.0553613819886076,0.0753265594015062,0.764618676609237
CR2,Complement receptor type 2,Diet and food preferences,X20739.Liking for vegetables,35063,0.0722400696325605,0.0389770983321812,-0.0041550430985146,0.148635182363636,0.0638531195547329
CR2,Complement receptor type 2,Diet and food preferences,X20740.Liking for vinegar,35063,-0.0408568250475679,0.0338545168275949,-0.107211678029654,0.0254980279345181,0.227522515145563
CR2,Complement receptor type 2,Diet and food preferences,X20741.Liking for watching television,35063,0.0288467841906459,0.0339391834907616,-0.0376740154512469,0.0953675838325387,0.395369208658808
CR2,Complement receptor type 2,Diet and food preferences,X20742.Liking for whisky,35063,-0.159182540467619,0.0355089682991208,-0.228780118333896,-0.0895849626013423,7.44143433427352e-06
CR2,Complement receptor type 2,Diet and food preferences,X20743.Liking for white bread,35063,-0.0238069181894407,0.0334348660023561,-0.0893392555540586,0.0417254191751773,0.476456485747112
CR2,Complement receptor type 2,Diet and food preferences,X20744.Liking for white rice,35063,-0.0162713185210063,0.0338561040547848,-0.0826292824683846,0.0500866454263719,0.630809159229673
CR2,Complement receptor type 2,Diet and food preferences,X20745.Liking for white wine,35063,-0.201936900769366,0.033600300726187,-0.267793490192693,-0.13608031134604,1.91659928677917e-09
CR2,Complement receptor type 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35063,0.0831074367072038,0.0340241256929925,0.0164201503489386,0.149794723065469,0.0145979749247978
CR2,Complement receptor type 2,Diet and food preferences,X20747.Liking for whole milk,35063,-0.040144958462672,0.0333933890250751,-0.105596000951819,0.0253060840264751,0.229319555407268
CR2,Complement receptor type 2,Diet and food preferences,X20748.Liking for wholemeal bread,35063,0.00500117133516982,0.0356451987757107,-0.0648634182652232,0.0748657609355628,0.888422306095092
CR2,Complement receptor type 2,Diet and food preferences,X20749.Liking for working up a sweat,35063,-0.0150858872319938,0.0334568804378317,-0.0806613728901439,0.0504895984261564,0.652066970684624
CR2,Complement receptor type 2,Physical measures,X21001.Body mass index (BMI),52212,-0.0517158419487018,0.0123076300170232,-0.0758387967820673,-0.0275928871153363,2.65471440319068e-05
CR2,Complement receptor type 2,Physical measures,X21002.Weight,52220,0.0207436241902643,0.00760581022003396,0.00583623615899773,0.0356510122215308,0.00638874750719032
CR2,Complement receptor type 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33597,0.00810450803931346,0.0055042451067947,-0.00268381237000416,0.0188928284486311,0.140944484974164
CR2,Complement receptor type 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34471,0.00750808857067222,0.0350824664466478,-0.0612535456647574,0.0762697228061018,0.830541617285714
CR2,Complement receptor type 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34485,-0.0484038207440827,0.0367294157769773,-0.120393475666958,0.0235858341787929,0.187584327566742
CR2,Complement receptor type 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34486,0.0945453198994662,0.0367627776647206,0.0224902756766139,0.166600364122319,0.0101323448880978
CR2,Complement receptor type 2,Health and medical history,X21040.Satisfaction with bowel habits,34438,-0.0325940975672712,0.0339920707979368,-0.0992185563312274,0.034030361196685,0.337645686924356
CR2,Complement receptor type 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34419,0.0281231678867559,0.0354747279929081,-0.041407298979344,0.0976536347528559,0.427932896760914
CR2,Complement receptor type 2,Health and medical history,X21042.Greatest number of times bowels opened per day,34431,0.00636701535775232,0.0366900436147176,-0.0655454701270941,0.0782795008425987,0.862234254291831
CR2,Complement receptor type 2,Health and medical history,X21043.Least number of times bowels opened per week,34339,-0.0128781530634553,0.0363281667356862,-0.0840813598654002,0.0583250537384896,0.722975519920049
CR2,Complement receptor type 2,Health and medical history,X21044.Average number of times bowels opened per day,34393,0.0243335542188749,0.0415311135277547,-0.0570674282955243,0.105734536733274,0.557948346421276
CR2,Complement receptor type 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34489,0.0112893959250303,0.0371998430705769,-0.0616222964933005,0.0842010883433611,0.761530632749825
CR2,Complement receptor type 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34483,-0.0292293350069361,0.0375192576524232,-0.102767080005686,0.0443084099918134,0.43596931142216
CR2,Complement receptor type 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34486,0.0546860199735084,0.0435400396383049,-0.0306524577175693,0.140024497664586,0.209147466207478
CR2,Complement receptor type 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34486,-0.0159357410318626,0.0388904771842468,-0.0921610763129864,0.0602895942492611,0.681991153855962
CR2,Complement receptor type 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34483,-0.049847468480956,0.0579168479889228,-0.163364490539245,0.0636695535773326,0.389438729319954
CR2,Complement receptor type 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34485,-0.0198246888868584,0.042605091243597,-0.103330667724309,0.0636812899505916,0.641717660982994
CR2,Complement receptor type 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34484,0.103125108729477,0.108276546558243,-0.109096922524679,0.315347139983633,0.340905282184064
CR2,Complement receptor type 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34488,-0.0503445907398646,0.0402580358718373,-0.129250341048666,0.0285611595689365,0.211128731047776
CR2,Complement receptor type 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34487,-0.0384752232696304,0.0425656179201491,-0.121903834393123,0.0449533878538619,0.366068120728963
CR2,Complement receptor type 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34221,0.0579537727089864,0.0379552342081793,-0.016438486339045,0.132346031757018,0.126818748020703
CR2,Complement receptor type 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34484,0.00743604468759493,0.0382248200152927,-0.0674846025423787,0.0823566919175685,0.845761356070481
CR2,Complement receptor type 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34486,-0.0695593491135693,0.0502821085466865,-0.168112281865075,0.0289935836379363,0.166578636763278
CR2,Complement receptor type 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34488,-0.0604094532760541,0.03718820417887,-0.133298333466639,0.0124794269145311,0.104316514057288
CR2,Complement receptor type 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34486,-0.0253353018662361,0.0372018534867298,-0.0982509347002265,0.0475803309677543,0.495872926374027
CR2,Complement receptor type 2,Working and living environment,X21100.Water hardness (USGS classification),52074,0.0343366865237797,0.0218302551331436,-0.00845061353718172,0.0771239865847412,0.115754721090973
CR2,Complement receptor type 2,Lifestyle factors,X2139.Age first had sexual intercourse,48382,0.0244325378555377,0.00387716210639869,0.0168333001269962,0.0320317755840791,2.99616084198395e-10
CR2,Complement receptor type 2,Health and medical history,X2149.Lifetime number of sexual partners,46843,-0.103432201655744,0.0245750456647309,-0.151599291158617,-0.0552651121528714,2.57696272120819e-05
CR2,Complement receptor type 2,Physical activities,X22032.IPAQ activity group,45918,-0.0618911570645522,0.0246908385711243,-0.110285200663956,-0.0134971134651485,0.0121956514844234
CR2,Complement receptor type 2,Physical activities,X22033.Summed days activity,46608,-0.010596294932859,0.00367903486602495,-0.0178072032702679,-0.00338538659545008,0.00397824908256462
CR2,Complement receptor type 2,Physical activities,X22034.Summed minutes activity,45918,-0.00774030969652748,0.00370610363751707,-0.0150042728260609,-0.000476346566994029,0.0367617784405232
CR2,Complement receptor type 2,Physical activities,X22037.MET minutes per week for walking,44872,-0.00405632671006335,0.00376037280658453,-0.011426657410969,0.00331400399084233,0.280732737445284
CR2,Complement receptor type 2,Physical activities,X22038.MET minutes per week for moderate activity,45918,-0.00839199862376849,0.00365895713990922,-0.0155635546179906,-0.00122044262954641,0.0218260158145744
CR2,Complement receptor type 2,Physical activities,X22039.MET minutes per week for vigorous activity,45918,-0.102435789194972,0.0248015486121026,-0.151046824474693,-0.0538247539152508,3.6379162449621e-05
CR2,Complement receptor type 2,Physical activities,X22040.Summed MET minutes per week for all activity,44872,-0.0098849570977182,0.00382826927940639,-0.0173883648853547,-0.00238154931008168,0.00982713708939146
CR2,Complement receptor type 2,Eye measures,X2217.Age started wearing glasses or contact lenses,48409,-0.0112273843992209,0.00351440417784817,-0.0181156165878033,-0.00433915221063852,0.0014016891844429
CR2,Complement receptor type 2,Working and living environment,X22501.Year ended full time education,31375,-0.0168001203941828,0.0163989488112823,-0.0489420600642961,0.0153418192759306,0.305652315045957
CR2,Complement receptor type 2,Lifestyle factors,X22506.Tobacco smoking,31330,0.0988963077115854,0.0942381750669378,-0.0858105154196127,0.283603130842784,0.294017434308801
CR2,Complement receptor type 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50423,-0.141965238709873,0.0515627799463485,-0.243028287404716,-0.0409021900150305,0.00590477646544828
CR2,Complement receptor type 2,Physical measures,X23098.Weight,51797,0.0230124465620491,0.00765164044689913,0.00801523128612685,0.0380096618379714,0.00263629913361433
CR2,Complement receptor type 2,Physical measures,X23099.Body fat percentage,51798,0.0104742360510297,0.0078667135920342,-0.00494452258935729,0.0258929946914168,0.183047895197135
CR2,Complement receptor type 2,Physical measures,X23100.Whole body fat mass,51789,0.0142181649352487,0.00753317776661216,-0.00054686348731115,0.0289831933578085,0.0591163221062646
CR2,Complement receptor type 2,Physical measures,X23101.Whole body fat-free mass,51797,0.0105616881558577,0.00630464064317476,-0.00179540750476488,0.0229187838164802,0.0939016358007338
CR2,Complement receptor type 2,Physical measures,X23102.Whole body water mass,51797,0.00999893482350132,0.00632766616987625,-0.00240329086945612,0.0224011605164588,0.114074203022479
CR2,Complement receptor type 2,Physical measures,X23104.Body mass index (BMI),51797,-0.0572564746885815,0.0124442200349857,-0.0816471459571535,-0.0328658034200096,4.22252678686119e-06
CR2,Complement receptor type 2,Physical measures,X23105.Basal metabolic rate,51795,0.0137658798202473,0.00687033688798079,0.000300019519804929,0.0272317401206896,0.0451153958437781
CR2,Complement receptor type 2,Physical measures,X23106.Impedance of whole body,51791,0.010444340744993,0.00515632559957662,0.000337942569822822,0.0205507389201632,0.0428217001981059
CR2,Complement receptor type 2,Physical measures,X23107.Impedance of leg (right),51794,0.00351193632464364,0.00421992922845343,-0.00475912496312508,0.0117829976124124,0.405288458363085
CR2,Complement receptor type 2,Physical measures,X23108.Impedance of leg (left),51793,0.00508509082590353,0.00417898504098808,-0.00310571985443312,0.0132759015062402,0.223681550543994
CR2,Complement receptor type 2,Physical measures,X23109.Impedance of arm (right),51784,0.00866867723666414,0.00516894815447357,-0.00146246114610406,0.0187998156194323,0.093540632021671
CR2,Complement receptor type 2,Physical measures,X23110.Impedance of arm (left),51792,0.0086394232378759,0.00518355164865801,-0.0015203379934938,0.0187991844692456,0.0955856155001393
CR2,Complement receptor type 2,Physical measures,X23111.Leg fat percentage (right),51793,0.0112916329652039,0.0124140406505942,-0.0130398867099608,0.0356231526403686,0.363049098777223
CR2,Complement receptor type 2,Physical measures,X23112.Leg fat mass (right),51792,0.0262145565762644,0.014247911682132,-0.00171135032071443,0.0541404634732432,0.0657955690112026
CR2,Complement receptor type 2,Physical measures,X23113.Leg fat-free mass (right),51792,0.0141162726559507,0.00640037605918454,0.001571535579949,0.0266610097319524,0.0274246536724901
CR2,Complement receptor type 2,Physical measures,X23114.Leg predicted mass (right),51791,0.0136476387907007,0.0064246603225509,0.00105530455850098,0.0262399730229005,0.0336574898871198
CR2,Complement receptor type 2,Physical measures,X23115.Leg fat percentage (left),51788,0.0185932375921076,0.0128091186016439,-0.0065126348671144,0.0436991100513296,0.146634738193213
CR2,Complement receptor type 2,Physical measures,X23116.Leg fat mass (left),51788,0.0219283728191512,0.0143071712921266,-0.00611368291341694,0.0499704285517194,0.125365300556532
CR2,Complement receptor type 2,Physical measures,X23117.Leg fat-free mass (left),51786,0.0143965386267648,0.00656488380578678,0.00152936636742267,0.0272637108861069,0.0283185356566344
CR2,Complement receptor type 2,Physical measures,X23118.Leg predicted mass (left),51785,0.0142056955901872,0.00658934036113488,0.00129058848236287,0.0271208026980116,0.0311032941797574
CR2,Complement receptor type 2,Physical measures,X23119.Arm fat percentage (right),51785,-0.0114251285272545,0.00873654480371685,-0.0285487563425395,0.00569849928803054,0.19097253231897
CR2,Complement receptor type 2,Physical measures,X23120.Arm fat mass (right),51781,-0.00571551428686675,0.00786029176440857,-0.0211216861451075,0.00969065757137404,0.467147849247949
CR2,Complement receptor type 2,Physical measures,X23121.Arm fat-free mass (right),51783,0.00987865954743361,0.00613627389333707,-0.00214843728350705,0.0219057563783743,0.107435785041512
CR2,Complement receptor type 2,Physical measures,X23122.Arm predicted mass (right),51782,0.0109612088417436,0.0061350966476614,-0.00106358058767279,0.0229859982711599,0.0740067788893704
CR2,Complement receptor type 2,Physical measures,X23123.Arm fat percentage (left),51779,-0.0130607787893629,0.00979758895935449,-0.0322640531496977,0.00614249557097192,0.182523065276692
CR2,Complement receptor type 2,Physical measures,X23124.Arm fat mass (left),51778,-0.0102162424518977,0.00806343139501398,-0.0260205679861251,0.00558808308232974,0.205171636569121
CR2,Complement receptor type 2,Physical measures,X23125.Arm fat-free mass (left),51778,0.0104510152673628,0.00661390376414208,-0.00251223611035568,0.0234142666450813,0.11408218123913
CR2,Complement receptor type 2,Physical measures,X23126.Arm predicted mass (left),51776,0.00684748290106091,0.0066250798667468,-0.00613767363776281,0.0198326394398846,0.301346441131326
CR2,Complement receptor type 2,Physical measures,X23127.Trunk fat percentage,51774,0.00874630001428383,0.00497113574196942,-0.00099712603997623,0.0184897260685439,0.0785179218522999
CR2,Complement receptor type 2,Physical measures,X23128.Trunk fat mass,51770,0.0169897127678304,0.00572596985383498,0.00576681185431384,0.028212613681347,0.00300851461179315
CR2,Complement receptor type 2,Physical measures,X23129.Trunk fat-free mass,51764,0.00854210799867444,0.00588990962698616,-0.00300211487021843,0.0200863308675673,0.146987684491451
CR2,Complement receptor type 2,Physical measures,X23130.Trunk predicted mass,51761,0.00887435575352082,0.00589969891792748,-0.00268905412561705,0.0204377656326587,0.132540192514933
CR2,Complement receptor type 2,NMR metabolomics,X23400.Total Cholesterol,40403,-0.0250429249019204,0.00438884390336458,-0.033645058952515,-0.0164407908513258,1.17686966047659e-08
CR2,Complement receptor type 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40403,-0.00365536350580347,0.00425212685040865,-0.0119895321326044,0.00467880512099748,0.389991985274683
CR2,Complement receptor type 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40403,0.00219692333525878,0.00424561238643614,-0.00612447694215605,0.0105183236126736,0.604844109712416
CR2,Complement receptor type 2,NMR metabolomics,X23403.VLDL Cholesterol,40403,0.0180931833899465,0.00416267000163679,0.00993435018673842,0.0262520165931546,1.3916218250078e-05
CR2,Complement receptor type 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,40403,-0.00638459844484036,0.0042571613723215,-0.0147286347345905,0.00195943784490977,0.133703793018625
CR2,Complement receptor type 2,NMR metabolomics,X23405.LDL Cholesterol,40403,-0.00898206257336974,0.00425398380541688,-0.0173198708319868,-0.000644254314752651,0.0347493956405575
CR2,Complement receptor type 2,NMR metabolomics,X23406.HDL Cholesterol,40403,-0.0737999267302244,0.00486912098539254,-0.0833434038615938,-0.064256449598855,1.56291341222344e-51
CR2,Complement receptor type 2,NMR metabolomics,X23407.Total Triglycerides,40403,0.00934954698132224,0.00450563000973545,0.000518512162240763,0.0181805818004037,0.0379950246006639
CR2,Complement receptor type 2,NMR metabolomics,X23408.Triglycerides in VLDL,40403,0.0160444138843742,0.00450646971978606,0.00721173323359348,0.0248770945351549,0.000371499571077341
CR2,Complement receptor type 2,NMR metabolomics,X23409.Triglycerides in LDL,40403,-0.0125918996432809,0.00448555988294072,-0.0213835970138447,-0.00380020227271707,0.00500335947855027
CR2,Complement receptor type 2,NMR metabolomics,X23410.Triglycerides in HDL,40403,-0.00963338157761913,0.00425221308449289,-0.0179677192232252,-0.00129904393201307,0.0234954655332314
CR2,Complement receptor type 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40403,-0.0435491038128473,0.00446022591673727,-0.0522911466096524,-0.0348070610160423,1.85956941330191e-22
CR2,Complement receptor type 2,NMR metabolomics,X23412.Phospholipids in VLDL,40403,0.0184763596867642,0.00428561036655064,0.010076563368325,0.0268761560052035,1.6330441562109e-05
CR2,Complement receptor type 2,NMR metabolomics,X23413.Phospholipids in LDL,40403,-0.00651969973950416,0.00422390121062096,-0.0147985461123212,0.00175914663331292,0.122723133520844
CR2,Complement receptor type 2,NMR metabolomics,X23414.Phospholipids in HDL,40403,-0.0736538492704189,0.00472328629897037,-0.0829114904164008,-0.064396208124437,2.02379581779459e-54
CR2,Complement receptor type 2,NMR metabolomics,X23415.Total Esterified Cholesterol,40403,-0.0289510852663468,0.00440168174558261,-0.0375783814876887,-0.0203237890450049,4.94035902450001e-11
CR2,Complement receptor type 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40403,0.017378453572911,0.00413844724860978,0.00926709696563581,0.0254898101801861,2.69231030770267e-05
CR2,Complement receptor type 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40403,-0.00806159090525452,0.00424497321170752,-0.0163817384002013,0.000258556589692222,0.0575705219911202
CR2,Complement receptor type 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40403,-0.0735742567401284,0.00483654860818469,-0.0830538920121703,-0.0640946214680864,6.79443900568932e-52
CR2,Complement receptor type 2,NMR metabolomics,X23419.Total Free Cholesterol,40403,-0.0150209801801495,0.00435394907342555,-0.0235547203640636,-0.00648723999623542,0.000562105334777598
CR2,Complement receptor type 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,40403,0.0187320735092473,0.00423577663715995,0.0104299513004138,0.0270341957180808,9.82802195419612e-06
CR2,Complement receptor type 2,NMR metabolomics,X23421.Free Cholesterol in LDL,40403,-0.0111444809841693,0.0042910315868103,-0.0195549028943175,-0.00273405907402109,0.00940853574102674
CR2,Complement receptor type 2,NMR metabolomics,X23422.Free Cholesterol in HDL,40403,-0.0701200235937688,0.0048920517341256,-0.079708444992655,-0.0605316021948827,2.62213580880508e-46
CR2,Complement receptor type 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40403,-0.022920629129903,0.00436872174587971,-0.0314833237518273,-0.0143579345079788,1.5697347554041e-07
CR2,Complement receptor type 2,NMR metabolomics,X23424.Total Lipids in VLDL,40403,0.0185183906624573,0.00437195842681649,0.009949352145897,0.0270874291790176,2.29098443100764e-05
CR2,Complement receptor type 2,NMR metabolomics,X23425.Total Lipids in LDL,40403,-0.00866998844978184,0.00424504060161491,-0.0169902680289471,-0.000349708870616612,0.0411302034241894
CR2,Complement receptor type 2,NMR metabolomics,X23426.Total Lipids in HDL,40403,-0.0738013226031782,0.00477996464263312,-0.0831700533027391,-0.0644325919036172,2.15309523484669e-53
CR2,Complement receptor type 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40403,-0.0680445410548754,0.00447103424021111,-0.0768077681656892,-0.0592813139440616,6.13015499724356e-52
CR2,Complement receptor type 2,NMR metabolomics,X23428.Concentration of VLDL Particles,40403,0.0146430086984877,0.00422275349936047,0.00636641183974115,0.0229196055572342,0.000526425071001567
CR2,Complement receptor type 2,NMR metabolomics,X23429.Concentration of LDL Particles,40403,0.00855240634953789,0.00421306026750509,0.000294808225227908,0.0168100044738479,0.0423756587417418
CR2,Complement receptor type 2,NMR metabolomics,X23430.Concentration of HDL Particles,40403,-0.0721330425405185,0.00447778910282134,-0.0809095091820483,-0.0633565758989887,6.30898612411279e-58
CR2,Complement receptor type 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40403,0.0268287056100718,0.00475012532824276,0.017518459966716,0.0361389512534276,1.6509456616157e-08
CR2,Complement receptor type 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,40403,-0.0289637732707341,0.00434524075102947,-0.0374804451427518,-0.0204471013987163,2.72169953560941e-11
CR2,Complement receptor type 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,40403,-0.0384109013342764,0.00514185972552633,-0.048488946396308,-0.0283328562722448,8.41918845077652e-14
CR2,Complement receptor type 2,NMR metabolomics,X23434.Phosphoglycerides,40388,-0.0507065958113862,0.00447997722451844,-0.0594873511714424,-0.0419258404513301,1.37851263294163e-29
CR2,Complement receptor type 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40388,0.0367239389876204,0.00476437252908228,0.0273857688306191,0.0460621091446217,1.35278450756981e-14
CR2,Complement receptor type 2,NMR metabolomics,X23436.Total Cholines,40388,-0.0494368803382094,0.0044908009421783,-0.0582388501848789,-0.0406349104915399,4.39099589301418e-28
CR2,Complement receptor type 2,NMR metabolomics,X23437.Phosphatidylcholines,40388,-0.0548177537376323,0.00448934497806697,-0.0636168698946436,-0.0460186375806211,3.87529417176793e-34
CR2,Complement receptor type 2,NMR metabolomics,X23438.Sphingomyelins,40387,-0.0409601205544232,0.00452475930608015,-0.0498286487943403,-0.0320915923145061,1.55679963706814e-19
CR2,Complement receptor type 2,NMR metabolomics,X23439.Apolipoprotein B,40403,0.00800737213210394,0.00421115955937278,-0.000246500604266713,0.0162612448684746,0.0572591457034312
CR2,Complement receptor type 2,NMR metabolomics,X23440.Apolipoprotein A1,40403,-0.07396208191187,0.00463054005250391,-0.0830379404147777,-0.0648862234089623,5.47964990708065e-57
CR2,Complement receptor type 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40403,0.0425963261161931,0.00424199123496043,0.0342820232956706,0.0509106289367155,1.17624783080161e-23
CR2,Complement receptor type 2,NMR metabolomics,X23442.Total Fatty Acids,40388,-0.0204179292633424,0.00450365717438666,-0.0292450973251402,-0.0115907612015445,5.83998596528944e-06
CR2,Complement receptor type 2,NMR metabolomics,X23443.Degree of Unsaturation,40388,-0.0121403504423076,0.0047427009357575,-0.0214360442763923,-0.00284465660822292,0.0104824809186612
CR2,Complement receptor type 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,40388,-0.0197671311561713,0.00442528804289141,-0.0284406957202385,-0.0110935665921041,7.99229436682188e-06
CR2,Complement receptor type 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,40388,-0.0196772895949434,0.00435369173566375,-0.0282105253968443,-0.0111440537930424,6.23790872965789e-06
CR2,Complement receptor type 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40388,-0.0222490904261383,0.004390982483852,-0.0308554160944882,-0.0136427647577884,4.08663229820464e-07
CR2,Complement receptor type 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40388,-0.00737566767739538,0.00462774430415166,-0.0164460465135326,0.00169471115874187,0.111002179604473
CR2,Complement receptor type 2,NMR metabolomics,X23448.Saturated Fatty Acids,40388,-0.0281081713073226,0.00459807883172416,-0.0371204058175019,-0.0190959367971432,1.00037639329371e-09
CR2,Complement receptor type 2,NMR metabolomics,X23449.Linoleic Acid,40388,-0.00938460929596689,0.00431311567208056,-0.0178383160132448,-0.000930902578688999,0.0295825676323122
CR2,Complement receptor type 2,NMR metabolomics,X23450.Docosahexaenoic Acid,40388,-0.0348832865478589,0.00464822554380561,-0.0439938086137178,-0.0257727644819999,6.48432239701379e-14
CR2,Complement receptor type 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40388,-0.0126744017590953,0.00442698298394314,-0.0213512884076238,-0.0039975151105667,0.00420212948842964
CR2,Complement receptor type 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40388,0.0139237046742215,0.00493439543360501,0.0042522896243557,0.0235951197240873,0.00478192477499336
CR2,Complement receptor type 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40388,0.00879377042764557,0.00495984055549811,-0.000927517061130718,0.0185150579164219,0.0762487021852768
CR2,Complement receptor type 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40388,0.0234232544498287,0.00488163062857018,0.0138552584178312,0.0329912504818263,1.6151272687242e-06
CR2,Complement receptor type 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40388,-0.0372986811795576,0.0046001228301777,-0.0463149219267059,-0.0282824404324093,5.50850911551979e-16
CR2,Complement receptor type 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40388,0.0186910713506372,0.00474890864981261,0.00938321039700445,0.0279989323042699,8.32490284346405e-05
CR2,Complement receptor type 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40388,-0.0223418037938861,0.00471524379875385,-0.0315836816394436,-0.0130999259483285,2.17477488880319e-06
CR2,Complement receptor type 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40388,-0.0108130607682795,0.00493796578586179,-0.0204914737085686,-0.00113464782799041,0.0285546115844277
CR2,Complement receptor type 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40386,0.013461266928893,0.00440593240877627,0.00482563940769152,0.0220968944500945,0.00225237481564163
CR2,Complement receptor type 2,NMR metabolomics,X23460.Alanine,40396,0.000796218789020811,0.00421453307854371,-0.00746426604492486,0.00905670362296648,0.850156211816425
CR2,Complement receptor type 2,NMR metabolomics,X23461.Glutamine,40353,0.0110196909986502,0.00425404252112671,0.00268176765724182,0.0193576143400585,0.00959506809833606
CR2,Complement receptor type 2,NMR metabolomics,X23462.Glycine,40382,0.0191566519165995,0.00406983218370339,0.0111797808365409,0.0271335229966581,2.53519106290511e-06
CR2,Complement receptor type 2,NMR metabolomics,X23463.Histidine,40382,0.000934141064405381,0.00414888556102464,-0.00719767463520291,0.00906595676401367,0.821861820522921
CR2,Complement receptor type 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40392,0.0127614067881057,0.00424640572855401,0.00443845156013981,0.0210843620160715,0.00265796750062164
CR2,Complement receptor type 2,NMR metabolomics,X23465.Isoleucine,40399,0.0107692655385716,0.00416552270676178,0.0026048410333185,0.0189336900438247,0.00973727361231236
CR2,Complement receptor type 2,NMR metabolomics,X23466.Leucine,40400,0.0112596812324817,0.00424406954607316,0.00294130492217833,0.0195780575427851,0.00798497246251886
CR2,Complement receptor type 2,NMR metabolomics,X23467.Valine,40392,0.012942774487506,0.00428216191165144,0.00454973714066918,0.0213358118343428,0.00251105822145505
CR2,Complement receptor type 2,NMR metabolomics,X23468.Phenylalanine,40399,0.0109689372549544,0.0041416160977475,0.00285136970336933,0.0190865048065395,0.00809371464069785
CR2,Complement receptor type 2,NMR metabolomics,X23469.Tyrosine,40383,0.0207771853241365,0.00417397252025272,0.0125961991844412,0.0289581714638319,6.49839548233839e-07
CR2,Complement receptor type 2,NMR metabolomics,X23470.Glucose,40370,0.0175971149660696,0.00439895623378053,0.00897516074785972,0.0262190691842794,6.3550073747368e-05
CR2,Complement receptor type 2,NMR metabolomics,X23471.Lactate,40370,-0.00685259630173518,0.00413080885530209,-0.0149489816581273,0.00124378905465691,0.0971557680459762
CR2,Complement receptor type 2,NMR metabolomics,X23472.Pyruvate,40354,-0.0211916721592978,0.00427458401124143,-0.029569856821331,-0.0128134874972646,7.21048954444368e-07
CR2,Complement receptor type 2,NMR metabolomics,X23473.Citrate,40401,0.0246462886852301,0.004234152384081,0.0163473500124313,0.0329452273580288,5.96797385009628e-09
CR2,Complement receptor type 2,NMR metabolomics,X23474.3-Hydroxybutyrate,40205,-0.0113491679448077,0.00399008860131855,-0.019169741603392,-0.00352859428622332,0.00445608909689703
CR2,Complement receptor type 2,NMR metabolomics,X23475.Acetate,40389,0.0153200041591531,0.00430493619672952,0.00688232921356326,0.023757679104743,0.000373769044413882
CR2,Complement receptor type 2,NMR metabolomics,X23476.Acetoacetate,40402,-0.0171041486037348,0.00413526507547231,-0.0252092681516605,-0.00899902905580909,3.54963705560232e-05
CR2,Complement receptor type 2,NMR metabolomics,X23477.Acetone,40402,-0.0200069684187862,0.00414546055312593,-0.0281320711029131,-0.0118818657346594,1.40425930278493e-06
CR2,Complement receptor type 2,NMR metabolomics,X23478.Creatinine,39921,0.0277156639003369,0.00487886547953904,0.0181530875604404,0.0372782402402334,1.36510811312722e-08
CR2,Complement receptor type 2,NMR metabolomics,X23479.Albumin,40401,0.0237188867563198,0.00428934202176821,0.0153117763936541,0.0321259971189855,3.25768101485746e-08
CR2,Complement receptor type 2,NMR metabolomics,X23480.Glycoprotein Acetyls,40403,0.00578586252015506,0.00456731232343101,-0.00316606963376972,0.0147377946740798,0.205245992349863
CR2,Complement receptor type 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40403,0.0234345805592911,0.00454984855880667,0.01451687738403,0.0323522837345521,2.62706059801335e-07
CR2,Complement receptor type 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40403,0.0260081196379474,0.00455099785418213,0.0170881638437504,0.0349280754321444,1.11783837855487e-08
CR2,Complement receptor type 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40403,0.02348084013918,0.00448234148958227,0.0146954508195988,0.0322662294587612,1.63926998918479e-07
CR2,Complement receptor type 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40403,0.0239392065112742,0.00447557070077536,0.0151670879377545,0.0327113250847939,8.97300912862482e-08
CR2,Complement receptor type 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40403,0.0251120932126388,0.00444787336647827,0.0163942614143414,0.0338299250109362,1.67152013813931e-08
CR2,Complement receptor type 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40403,0.0213092162598464,0.00449821496255386,0.0124927149332409,0.030125717586452,2.1849267476299e-06
CR2,Complement receptor type 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40403,0.0265454339275441,0.00458551791120131,0.0175578188215895,0.0355330490334987,7.21491393478449e-09
CR2,Complement receptor type 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40403,0.0221424544176516,0.00446402692000175,0.0133929616544482,0.0308919471808551,7.11461802361441e-07
CR2,Complement receptor type 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40403,0.0238487946716324,0.00447273962636192,0.0150822250039631,0.0326153643393018,9.84424703635471e-08
CR2,Complement receptor type 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40403,0.0261899381650337,0.00443371413925423,0.0174998584520954,0.034880017877972,3.55484820839494e-09
CR2,Complement receptor type 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40403,0.0271554060156333,0.00430907425300195,0.0187096204797495,0.0356011915515171,3.01713074022111e-10
CR2,Complement receptor type 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40403,0.0268308119787701,0.00422218120123472,0.01855533682435,0.0351062871331901,2.1446039354338e-10
CR2,Complement receptor type 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40403,0.026783110701539,0.00440113063950312,0.0181568946481129,0.0354093267549651,1.18778629612217e-09
CR2,Complement receptor type 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40403,0.0199555760300512,0.00452548507935634,0.0110856252745127,0.0288255267855896,1.04239382559192e-05
CR2,Complement receptor type 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40403,0.0220331907959406,0.00442124161508804,0.013367557230368,0.0306988243615131,6.31034967664304e-07
CR2,Complement receptor type 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,40403,0.0221039172999049,0.00441256072980753,0.0134552982694822,0.0307525363303277,5.5207309707934e-07
CR2,Complement receptor type 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,40403,0.0232342466022232,0.00439054417769116,0.0146287800139485,0.0318397131904978,1.2266473692548e-07
CR2,Complement receptor type 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,40403,0.0251324682504083,0.0042646945305778,0.0167736669704758,0.0334912695303408,3.86546419973922e-09
CR2,Complement receptor type 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40403,0.0256886385556085,0.00416338029009384,0.0175284131870246,0.0338488639241925,6.98770879321952e-10
CR2,Complement receptor type 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40403,0.0239134180820984,0.00437471663137159,0.01533897348461,0.0324878626795867,4.66481592616633e-08
CR2,Complement receptor type 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,40403,0.0183134895530463,0.00448063768515149,0.00953143969014941,0.0270955394159432,4.3865240554926e-05
CR2,Complement receptor type 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40403,0.0158282699735421,0.00419736058125535,0.00760144323428158,0.0240550967128026,0.000163177977295201
CR2,Complement receptor type 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40403,0.0150817071497817,0.00424054098199843,0.00677024682506474,0.0233931674744986,0.000376841972179484
CR2,Complement receptor type 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40403,0.0146273206481733,0.00418704439195241,0.0064207136399466,0.0228339276564001,0.00047807581570654
CR2,Complement receptor type 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40403,0.0131662373377561,0.00421989885353705,0.0048952355848235,0.0214372390906887,0.0018115120321004
CR2,Complement receptor type 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40403,0.0112345105507794,0.00429143196331707,0.00282330390267791,0.0196457171988808,0.00885580512102119
CR2,Complement receptor type 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40403,0.0147111830860565,0.00417663898418285,0.00652497067705808,0.0228973954950548,0.000429089763794702
CR2,Complement receptor type 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40403,0.0133711097407918,0.00439844828296089,0.00475015110618846,0.0219920683753951,0.00236992559414233
CR2,Complement receptor type 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40403,0.0168704143075011,0.00422693135026789,0.00858562886097607,0.0251551997540262,6.60413875442165e-05
CR2,Complement receptor type 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,40403,0.0148373155666099,0.00420428615900859,0.0065969146949531,0.0230777164382668,0.000418160740463946
CR2,Complement receptor type 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,40403,0.0140157067981112,0.00415560277827629,0.00587072535268969,0.0221606882435327,0.000746050992437926
CR2,Complement receptor type 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,40403,0.0177290041727345,0.00410912300738674,0.0096751230782565,0.0257828852672125,1.60892884180595e-05
CR2,Complement receptor type 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40403,0.0202135850010715,0.00408476615205497,0.0122074433430437,0.0282197266590992,7.55387328664004e-07
CR2,Complement receptor type 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40403,0.0127451306809445,0.0041642289166213,0.00458324200436678,0.0209070193575223,0.00221244742962432
CR2,Complement receptor type 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,40403,0.00926072719974895,0.00436164037129899,0.00071191207200294,0.017809542327495,0.0337506752896813
CR2,Complement receptor type 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40403,0.00535564314366582,0.00425521315979727,-0.00298457464953683,0.0136958609368685,0.208190561764812
CR2,Complement receptor type 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40403,0.00297696131566342,0.00425329233484403,-0.00535949166063088,0.0113134142919577,0.48398792240822
CR2,Complement receptor type 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40403,0.00598641071605674,0.0042459706196735,-0.00233569169850332,0.0143085131306168,0.158587545943143
CR2,Complement receptor type 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40403,0.00120167725550955,0.00432997805472706,-0.00728507973175549,0.00968843424277458,0.781380591780738
CR2,Complement receptor type 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40403,-0.00083791881087888,0.00436157336650281,-0.00938660260922439,0.00771076498746663,0.847655443160777
CR2,Complement receptor type 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40403,0.00555819834947338,0.00426513973698124,-0.00280147553500986,0.0139178722339566,0.192535844338381
CR2,Complement receptor type 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40403,0.000585983688937285,0.00433283021639212,-0.00790636353519127,0.00907833091306584,0.89242168815967
CR2,Complement receptor type 2,NMR metabolomics,X23523.Concentration of IDL Particles,40403,0.000896637712063719,0.00427040659024922,-0.00747335920482476,0.0092666346289522,0.833697344119481
CR2,Complement receptor type 2,NMR metabolomics,X23524.Total Lipids in IDL,40403,-0.016098782434836,0.0043821944137646,-0.0246878834858146,-0.00750968138385736,0.000239863773594654
CR2,Complement receptor type 2,NMR metabolomics,X23525.Phospholipids in IDL,40403,-0.011623873072895,0.00439730357184468,-0.0202425880737106,-0.00300515807207946,0.00821560028168018
CR2,Complement receptor type 2,NMR metabolomics,X23526.Cholesterol in IDL,40403,-0.0171617081388907,0.00438756216283759,-0.0257613299780524,-0.008562086299729,9.21257408998578e-05
CR2,Complement receptor type 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40403,-0.0193877925412081,0.00437599175157051,-0.0279647363742863,-0.0108108487081299,9.4644881766754e-06
CR2,Complement receptor type 2,NMR metabolomics,X23528.Free Cholesterol in IDL,40403,-0.0103524895948743,0.0044156106933083,-0.0190070865537586,-0.00169789263599006,0.0190637631628588
CR2,Complement receptor type 2,NMR metabolomics,X23529.Triglycerides in IDL,40403,-0.0101477887976913,0.0043914549156637,-0.0187550404323921,-0.0015405371629904,0.0208564081169466
CR2,Complement receptor type 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,40403,0.0050029843925563,0.00423240997143815,-0.00329253915146247,0.0132985079365751,0.237197466006475
CR2,Complement receptor type 2,NMR metabolomics,X23531.Total Lipids in Large LDL,40403,-0.0138212945486349,0.00427718000933866,-0.0222045673669387,-0.00543802173033113,0.00123433818582564
CR2,Complement receptor type 2,NMR metabolomics,X23532.Phospholipids in Large LDL,40403,-0.0103846910733619,0.00425929494719525,-0.0187329091698646,-0.0020364729768592,0.0147745308677159
CR2,Complement receptor type 2,NMR metabolomics,X23533.Cholesterol in Large LDL,40403,-0.0142313717530065,0.00429018449687733,-0.022640133366886,-0.00582261013912689,0.000911298992562454
CR2,Complement receptor type 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40403,-0.0138444402995288,0.00427219092139971,-0.0222179345054722,-0.00547094609358534,0.00119525093340106
CR2,Complement receptor type 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40403,-0.0150083214614621,0.00433615381566735,-0.0235071829401701,-0.00650945998275408,0.000539168996162795
CR2,Complement receptor type 2,NMR metabolomics,X23536.Triglycerides in Large LDL,40403,-0.0167024939013617,0.00444871336876701,-0.025421972104145,-0.00798301569857837,0.000174335864997498
CR2,Complement receptor type 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40403,0.0120770007432774,0.00420483906464701,0.00383551617656927,0.0203184853099856,0.00408204564212305
CR2,Complement receptor type 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,40403,-0.00152111389458566,0.0042209951126168,-0.00979426431531458,0.00675203652614326,0.718576312809309
CR2,Complement receptor type 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,40403,-0.00250278607179984,0.00419144529395312,-0.010718018847948,0.00571244670434828,0.550437292927508
CR2,Complement receptor type 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,40403,-0.000803656631770518,0.00422150833709432,-0.00907781297247539,0.00747049970893436,0.849020125392838
CR2,Complement receptor type 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40403,0.00125913065691798,0.00423591170009609,-0.00704325627527036,0.00956151758910631,0.766278458205914
CR2,Complement receptor type 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40403,-0.00637313460124368,0.00422505250720899,-0.0146542375153733,0.00190796831288595,0.13146802916697
CR2,Complement receptor type 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,40403,-0.00897135732597261,0.00451543812558738,-0.0178216160521239,-0.000121098599821356,0.0469595604231568
CR2,Complement receptor type 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,40403,0.0163034635548198,0.00418918531157755,0.00809266034412784,0.0245142667655118,9.9908590584488e-05
CR2,Complement receptor type 2,NMR metabolomics,X23545.Total Lipids in Small LDL,40403,0.00410304952235859,0.00422713280733245,-0.00418213078001302,0.0123882298247302,0.331739312085072
CR2,Complement receptor type 2,NMR metabolomics,X23546.Phospholipids in Small LDL,40403,0.00232396402861517,0.004206170417021,-0.00592012998874599,0.0105680580459763,0.580604640562813
CR2,Complement receptor type 2,NMR metabolomics,X23547.Cholesterol in Small LDL,40403,0.00423574496371101,0.0042168655014492,-0.00402931141912943,0.0125008013465514,0.315163925622305
CR2,Complement receptor type 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40403,0.00541467890609571,0.00424284335523781,-0.0029012940701704,0.0137306518823618,0.201906557158986
CR2,Complement receptor type 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40403,0.000522170573131615,0.00419845631696261,-0.00770680380811511,0.00875114495437834,0.901022278195112
CR2,Complement receptor type 2,NMR metabolomics,X23550.Triglycerides in Small LDL,40403,0.0044269538231838,0.0045544510584006,-0.00449977025128139,0.013353677897649,0.331062295263085
CR2,Complement receptor type 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40403,-0.0296869804162573,0.00488326181009402,-0.0392581735640416,-0.020115787268473,1.23431129735964e-09
CR2,Complement receptor type 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40403,-0.0296720029297826,0.00491743326988838,-0.0393101721387639,-0.0200338337208014,1.63443809054853e-09
CR2,Complement receptor type 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40403,-0.0295079559519162,0.00492178951222027,-0.039154663395868,-0.0198612485079645,2.07398277137193e-09
CR2,Complement receptor type 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40403,-0.0297736674872804,0.00488448101111687,-0.0393472502690694,-0.0202000847054913,1.1156201652889e-09
CR2,Complement receptor type 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40403,-0.0346197372573698,0.00496098726943309,-0.0443432723054587,-0.0248962022092809,3.10318767088193e-12
CR2,Complement receptor type 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40403,-0.0124423009533968,0.00455737626465878,-0.021374758432128,-0.00350984347466558,0.00633758346471759
CR2,Complement receptor type 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40403,-0.00531274898127695,0.00440202623473944,-0.0139407204013663,0.00331522243881236,0.227493497056867
CR2,Complement receptor type 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,40403,-0.0578982996528379,0.00515687367212614,-0.0680057720502052,-0.0477908272554707,3.84742280271146e-29
CR2,Complement receptor type 2,NMR metabolomics,X23559.Total Lipids in Large HDL,40403,-0.0597269578164923,0.00512918599874465,-0.0697801623740318,-0.0496737532589528,3.27229446961948e-31
CR2,Complement receptor type 2,NMR metabolomics,X23560.Phospholipids in Large HDL,40403,-0.0622013193080048,0.00506122693746657,-0.0721213241054393,-0.0522813145105703,1.47341723389481e-34
CR2,Complement receptor type 2,NMR metabolomics,X23561.Cholesterol in Large HDL,40403,-0.0561265374613921,0.00513036224711898,-0.0661820474657453,-0.0460710274570389,9.30440103192677e-28
CR2,Complement receptor type 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40403,-0.0558605706877558,0.00511636359468826,-0.0658886433333448,-0.0458324980421668,1.18421120700916e-27
CR2,Complement receptor type 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40403,-0.0553112432161048,0.00512372051495979,-0.0653537354254259,-0.0452687510067836,4.50190175172527e-27
CR2,Complement receptor type 2,NMR metabolomics,X23564.Triglycerides in Large HDL,40403,-0.0201593171691529,0.0043530808147322,-0.028691355566028,-0.0116272787722778,3.66695136915818e-06
CR2,Complement receptor type 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40403,-0.0745032329684451,0.00459276023844256,-0.0835050430357926,-0.0655014229010977,1.04176876842134e-58
CR2,Complement receptor type 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,40403,-0.0745051034476455,0.00455205945840581,-0.0834271399861208,-0.0655830669091701,1.00349184529537e-59
CR2,Complement receptor type 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,40403,-0.0727390067486458,0.00452563813622823,-0.0816092574956531,-0.0638687560016385,1.1256088071266e-57
CR2,Complement receptor type 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,40403,-0.0768111371463239,0.00460570585222263,-0.0858383206166803,-0.0677839536759676,6.40078850650499e-62
CR2,Complement receptor type 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40403,-0.0764980452255462,0.00458267805032253,-0.0854800942041784,-0.067515996246914,4.96105463443408e-62
CR2,Complement receptor type 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40403,-0.0754781818631676,0.00466520395582103,-0.0846219816165769,-0.0663343821097584,2.07001078336614e-58
CR2,Complement receptor type 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,40403,-0.0125480832521927,0.00421587444415499,-0.0208111971627365,-0.00428496934164895,0.00292102054180486
CR2,Complement receptor type 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,40403,-0.0471730872190264,0.00415010429017926,-0.0553072916277777,-0.039038882810275,7.97669714322255e-30
CR2,Complement receptor type 2,NMR metabolomics,X23573.Total Lipids in Small HDL,40403,-0.0519867540413582,0.00419267926678381,-0.0602044054042545,-0.043769102678462,3.82220858499416e-35
CR2,Complement receptor type 2,NMR metabolomics,X23574.Phospholipids in Small HDL,40403,-0.0558537004026139,0.00423537539531339,-0.0641550361774281,-0.0475523646277996,1.66861441974015e-39
CR2,Complement receptor type 2,NMR metabolomics,X23575.Cholesterol in Small HDL,40403,-0.0509878499616845,0.00415595798840073,-0.0591335276189499,-0.0428421723044191,1.90905621091571e-34
CR2,Complement receptor type 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40403,-0.0464983694255055,0.00411350397265735,-0.0545608372119139,-0.0384359016390971,1.62664928776486e-29
CR2,Complement receptor type 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40403,-0.0565044049085779,0.00430184900653829,-0.064936028961393,-0.0480727808557629,3.31888596141988e-39
CR2,Complement receptor type 2,NMR metabolomics,X23578.Triglycerides in Small HDL,40403,0.00485633052976734,0.00434959670488835,-0.00366887901181382,0.0133815400713485,0.264224416881035
CR2,Complement receptor type 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39526,-0.00153026575647173,0.00395633760950752,-0.00928468747110648,0.00622415595816302,0.698918276327981
CR2,Complement receptor type 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39526,-0.0034373836157132,0.00415547675785395,-0.0115821180611069,0.00470735082968055,0.408140454947741
CR2,Complement receptor type 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39526,0.00131317386683719,0.0040532762713472,-0.00663124762500332,0.00925759535867771,0.745958899833878
CR2,Complement receptor type 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39526,-0.0105892045964941,0.00422784130458611,-0.0188757735534829,-0.00230263563950533,0.0122682092130129
CR2,Complement receptor type 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39526,0.00140053096439095,0.00402888306104376,-0.00649607983525481,0.00929714176403672,0.728128455071354
CR2,Complement receptor type 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,40164,0.0301080206996858,0.00389574924500813,0.0224723521794698,0.0377436892199017,1.1544207002305e-14
CR2,Complement receptor type 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,40164,0.00611061044582735,0.00442795272309595,-0.00256817689144072,0.0147893977830954,0.167603798843347
CR2,Complement receptor type 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,40164,0.00194645161874484,0.00443953136729722,-0.00675502986115771,0.0106479330986474,0.661076079433509
CR2,Complement receptor type 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,40164,0.0195809726839709,0.00419333359766291,0.0113620388325516,0.0277999065353902,3.04360678846857e-06
CR2,Complement receptor type 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,40164,-0.0157706640033065,0.00424774804611968,-0.0240962501737011,-0.00744507783291197,0.000205759046654299
CR2,Complement receptor type 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40398,0.0198605894564746,0.00415180865902399,0.0117230444847876,0.0279981344281617,1.73724148714162e-06
CR2,Complement receptor type 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40398,0.0174059677800769,0.00409665558478866,0.00937652283389117,0.0254354127262627,2.16115704113975e-05
CR2,Complement receptor type 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40398,0.0147869553214778,0.00430122907614839,0.00635654633222698,0.0232173643107287,0.000587862270811571
CR2,Complement receptor type 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40398,0.0191566304490373,0.00394121666174368,0.0114318457920197,0.026881415106055,1.18151286949333e-06
CR2,Complement receptor type 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40398,-0.0215744181642166,0.00386881117737678,-0.0291572880718751,-0.0139915482565581,2.49392463602447e-08
CR2,Complement receptor type 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40403,0.00371994844612234,0.00433258324714675,-0.0047719147182853,0.01221181161053,0.390575098928265
CR2,Complement receptor type 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40403,0.00249421644068056,0.0045326272380886,-0.00638973294597309,0.0113781658273342,0.582134693630286
CR2,Complement receptor type 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40403,0.00153833794046596,0.00456469018905289,-0.0074084548300777,0.0104851307110096,0.736115166350166
CR2,Complement receptor type 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40403,0.00487479326042288,0.00443222132661585,-0.00381236053974418,0.0135619470605899,0.271412642654405
CR2,Complement receptor type 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40403,-0.00280827312657038,0.00449898080272445,-0.0116262754999103,0.00600972924676953,0.532503815085489
CR2,Complement receptor type 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40403,-0.00169098015287887,0.00441540863722128,-0.0103451810818326,0.00696322077607483,0.701745246013866
CR2,Complement receptor type 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40403,0.0146684263598824,0.00431620611850611,0.00620866236761038,0.0231281903521543,0.000679336744340304
CR2,Complement receptor type 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40403,0.0245803063937435,0.004190834627895,0.0163662705230693,0.0327943422644177,4.57317573598325e-09
CR2,Complement receptor type 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40403,-0.00226086551590035,0.00443031238034056,-0.0109442777813678,0.00642254674956715,0.609836172686987
CR2,Complement receptor type 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40403,-0.0100734709006552,0.0043536361765574,-0.0186065978067077,-0.00154034399460269,0.0206909943260529
CR2,Complement receptor type 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40403,0.0268237692326436,0.00442350878740585,0.0181536920093281,0.0354938464559591,1.35845125952947e-09
CR2,Complement receptor type 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40403,-0.00203339626589533,0.00460080474467772,-0.0110509735654637,0.006984181033673,0.658520273733756
CR2,Complement receptor type 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40403,-0.0057350335545726,0.00462894110144297,-0.0148077581134008,0.00333769100425562,0.215381687483569
CR2,Complement receptor type 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40403,0.0206749890675808,0.0044926780987656,0.0118693399940002,0.0294806381411613,4.21819516888475e-06
CR2,Complement receptor type 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40403,-0.0038629571151962,0.00459265893014065,-0.0128645686182719,0.00513865438787948,0.400295779905357
CR2,Complement receptor type 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40403,0.0291529198863128,0.00412716516506605,0.0210636761627834,0.0372421636098423,1.6886530962779e-12
CR2,Complement receptor type 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40403,-0.0153183885617653,0.00437263914845002,-0.0238887612927274,-0.0067480158308033,0.00046090006705459
CR2,Complement receptor type 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40403,-0.0271735446656693,0.00435266977049561,-0.0357047774158407,-0.0186423119154979,4.40224754910356e-10
CR2,Complement receptor type 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40403,0.0197151248746632,0.0044972119534239,0.0109005894459524,0.0285296603033741,1.17343114958721e-05
CR2,Complement receptor type 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40403,0.00423577654439608,0.00451977487705748,-0.00462298221463658,0.0130945353034288,0.348687683222734
CR2,Complement receptor type 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40403,0.0257916497996029,0.00410936855341858,0.0177372874349025,0.0338460121643033,3.55669156115365e-10
CR2,Complement receptor type 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40403,-0.0140082924862025,0.00452782509519299,-0.0228828296727808,-0.00513375529962425,0.00197936439982036
CR2,Complement receptor type 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40403,-0.00938102050605854,0.0041717691972524,-0.0175576881326732,-0.00120435287944384,0.0245457432883389
CR2,Complement receptor type 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40403,-0.00817172857404093,0.00452639634182276,-0.0170434654040135,0.00070000825593167,0.0710388139836788
CR2,Complement receptor type 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40403,-0.00292682399486159,0.0045054879665344,-0.011757580409269,0.00590393241954584,0.515951524662046
CR2,Complement receptor type 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40403,-0.00806829145933281,0.00407817160933906,-0.0160615078136374,-7.50751050282439e-05,0.0478997602502505
CR2,Complement receptor type 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40403,0.00997687596016189,0.00419978020278938,0.00174530676269469,0.0182084451576291,0.0175335673546722
CR2,Complement receptor type 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40403,0.0197058471059308,0.00425160219837101,0.0113727067971236,0.028038987414738,3.5989883276553e-06
CR2,Complement receptor type 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40403,-0.014610367747407,0.00460878016459161,-0.0236435768700065,-0.00557715862480741,0.0015266616220877
CR2,Complement receptor type 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40403,-0.00741990761607402,0.00435215055765158,-0.0159501227090711,0.00111030747692307,0.0882357150359411
CR2,Complement receptor type 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40403,-0.0071235607779933,0.00416171253985078,-0.0152805173561008,0.00103339580011422,0.0869732942433679
CR2,Complement receptor type 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40403,0.0051610990608855,0.00421978495249328,-0.00310967944600134,0.0134318775677723,0.221320729640441
CR2,Complement receptor type 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40403,0.00827883835569513,0.00420053885552544,4.5782198865257e-05,0.016511894512525,0.0487526770412618
CR2,Complement receptor type 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40403,-0.00352604088207214,0.00451052452901472,-0.012366668958941,0.00531458719479671,0.434381150427051
CR2,Complement receptor type 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40403,0.00147505074980651,0.00445751073686669,-0.0072616702944522,0.0102117717940652,0.740714125190332
CR2,Complement receptor type 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40401,-0.0274185880561157,0.00479101190542735,-0.0368089713907533,-0.0180282047214781,1.0658821315571e-08
CR2,Complement receptor type 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40401,0.0144899159178268,0.0047827136977873,0.00511579707016371,0.0238640347654899,0.00245234817269579
CR2,Complement receptor type 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40401,-0.0226305648001502,0.00479191566345788,-0.0320227195005277,-0.0132384100997728,2.34767279108431e-06
CR2,Complement receptor type 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40401,0.0563171400596128,0.00506787899175714,0.0463840972357688,0.0662501828834568,1.38772228372725e-28
CR2,Complement receptor type 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40401,0.0193042128267761,0.00477581203121328,0.00994362124559807,0.0286648044079541,5.32279040701854e-05
CR2,Complement receptor type 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40403,-0.00778406726675672,0.00497613266940684,-0.0175372872987941,0.0019691527652807,0.117771548561982
CR2,Complement receptor type 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40403,-0.0119709707860744,0.00494948387301681,-0.0216719591771873,-0.00226998239496143,0.0155901930897895
CR2,Complement receptor type 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40403,-0.0113028808641867,0.0049976414936016,-0.0210982581916459,-0.00150750353672761,0.0237328735200613
CR2,Complement receptor type 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40403,-0.00862549329724834,0.00479995659638527,-0.0180334082261635,0.000782421631666799,0.0723554790950563
CR2,Complement receptor type 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40403,0.0298367869547898,0.00479711360132132,0.0204344442962001,0.0392391296133796,5.10397949963154e-10
CR2,Complement receptor type 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40403,0.0360551574322776,0.00468426512021133,0.0268739977966634,0.0452363170678918,1.4733585051649e-14
CR2,Complement receptor type 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40403,-0.0336974589945466,0.00456699857672838,-0.0426487762049342,-0.0247461417841589,1.67999204001213e-13
CR2,Complement receptor type 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40403,-0.0245320253038821,0.0045409756510066,-0.033432337579855,-0.0156317130279091,6.6709478049364e-08
CR2,Complement receptor type 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40403,-0.0547051955232804,0.00489286449832862,-0.0642952099400045,-0.0451151811065564,6.49928916432333e-29
CR2,Complement receptor type 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40403,0.0294979022250889,0.00444519905461402,0.0207853120780454,0.0382104923721324,3.32913708319021e-11
CR2,Complement receptor type 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40403,-0.0277801035285136,0.00435153407949746,-0.0363091103243286,-0.0192510967326986,1.77311103885564e-10
CR2,Complement receptor type 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40403,-0.00181750220017092,0.0043647170764737,-0.0103723476700594,0.00673734326971752,0.6771172304132
CR2,Complement receptor type 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40403,0.000851672429649675,0.00437481055942803,-0.00772295626682927,0.00942630112612862,0.845648757169941
CR2,Complement receptor type 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40403,-0.0103115219357612,0.00444409175265592,-0.0190219417709668,-0.00160110210055554,0.0203384725765102
CR2,Complement receptor type 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40403,0.0325387040621177,0.00443893936471956,0.0238383829072674,0.041239025216968,2.40666524998824e-13
CR2,Complement receptor type 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51917,-0.00240643355906443,0.00361184292919829,-0.00948564570029306,0.00467277858216421,0.505249269842776
CR2,Complement receptor type 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51917,-0.00135409390559559,0.00353826200458999,-0.00828908743459196,0.00558089962340078,0.701944958745014
CR2,Complement receptor type 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50049,-0.000851847331522182,0.00336578459570529,-0.00744878513910455,0.00574509047606018,0.800200490158557
CR2,Complement receptor type 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50049,-0.000669274681233364,0.00366357535218937,-0.00784988237152454,0.00651133300905781,0.855047828296227
CR2,Complement receptor type 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50049,-0.0017115976781663,0.0035964880305106,-0.00876071421796707,0.00533751886163448,0.634143934061192
CR2,Complement receptor type 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50049,-0.0034294954862097,0.00329513432645437,-0.00988795876606027,0.00302896779364086,0.29798952569457
CR2,Complement receptor type 2,Working and living environment,X24009.Traffic intensity on the nearest road,51917,-0.0204274753819201,0.0481447031996126,-0.114791093653161,0.0739361428893206,0.671355242441129
CR2,Complement receptor type 2,Working and living environment,X24010.Inverse distance to the nearest road,51917,-0.00363907742139974,0.00315284155726211,-0.00981864687363347,0.00254049203083399,0.248419424972922
CR2,Complement receptor type 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51917,-1.07055261019038e-05,0.00316240855828373,-0.00620902630033801,0.0061876152481342,0.997298995443369
CR2,Complement receptor type 2,Working and living environment,X24012.Inverse distance to the nearest major road,51917,-0.000505978620393242,0.00321637532033046,-0.00681007424824093,0.00579811700745445,0.874999094124557
CR2,Complement receptor type 2,Working and living environment,X24013.Total traffic load on major roads,51917,-0.0020238738558984,0.0334632908664896,-0.067611923954218,0.0635641762424212,0.951773450664895
CR2,Complement receptor type 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51917,-0.0209545577994714,0.0324838203253078,-0.0846228456370746,0.0427137300381318,0.51888282729617
CR2,Complement receptor type 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51917,-0.000281688558443605,0.00359235442548355,-0.00732270323239136,0.00675932611550415,0.937499822699432
CR2,Complement receptor type 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51917,-0.000995895425223508,0.00358401586276518,-0.00802056651624327,0.00602877566579625,0.78111318789286
CR2,Complement receptor type 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51917,5.70456809932062e-05,0.00355026766543517,-0.00690147894325974,0.00701557030524615,0.987180263693005
CR2,Complement receptor type 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51851,0.00189719869364509,0.00349881464756354,-0.00496047801557944,0.00875487540286963,0.587657309582696
CR2,Complement receptor type 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51917,-0.00308392847544672,0.00317851344226985,-0.00931381482229562,0.00314595787140219,0.33193423044457
CR2,Complement receptor type 2,Working and living environment,X24021.Average evening sound level of noise pollution,51917,-0.00300948894123426,0.00317813676277804,-0.00923863699627921,0.00321965911381069,0.343680231862587
CR2,Complement receptor type 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51917,-0.00308407518381404,0.00317844618825204,-0.00931382971278804,0.00314567934515996,0.33190099944621
CR2,Complement receptor type 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51917,-0.00299212431866782,0.00317815049632225,-0.00922129929145944,0.0032370506541238,0.346473791799664
CR2,Complement receptor type 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51917,-0.00300142089516214,0.00317811819085823,-0.00923053254924427,0.00322769075892,0.34497261258009
CR2,Complement receptor type 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48963,-0.000208442121111563,0.00368053542392899,-0.00742229155201238,0.00700540730978925,0.954837497686291
CR2,Complement receptor type 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48963,0.00543694138827426,0.0033556556478258,-0.0011401436814643,0.0120140264580128,0.105195267349372
CR2,Complement receptor type 2,Working and living environment,"X24502.Water percentage, buffer 1000m",48963,-4.18631719088421e-06,0.0032986645792934,-0.00646956889260595,0.00646119625822418,0.998987419663895
CR2,Complement receptor type 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48963,-0.000490266298896433,0.00346921865002111,-0.00728993485293782,0.00630940225514495,0.887619149938295
CR2,Complement receptor type 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48963,0.00315796982876136,0.00338157646500432,-0.00346992004264711,0.00978585970016983,0.35037755905275
CR2,Complement receptor type 2,Working and living environment,"X24505.Water percentage, buffer 300m",48963,0.000364061873580153,0.00331281705879604,-0.00612905956166009,0.0068571833088204,0.912493585232368
CR2,Complement receptor type 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52074,-0.00329552412474021,0.0035277759880087,-0.0102099650612373,0.00361891681175684,0.350227059723731
CR2,Complement receptor type 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52074,-0.00339469618586991,0.00332853053839082,-0.00991861604111592,0.00312922366937611,0.307795097654469
CR2,Complement receptor type 2,Working and living environment,X24508.Distance (Euclidean) to coast,52074,-0.00151412236085678,0.00317816552049555,-0.00774332678102806,0.0047150820593145,0.633783273031484
CR2,Complement receptor type 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35693,-0.0401281041114714,0.0359194448464739,-0.11053021601056,0.0302740077876175,0.263945787033113
CR2,Complement receptor type 2,Health and medical history,X2704.Years since last cervical smear test,45582,0.0294843241563117,0.0259365225872102,-0.0213512601146203,0.0803199084272437,0.255639869387634
CR2,Complement receptor type 2,Health and medical history,X2714.Age when periods started (menarche),51411,-0.0316500536295752,0.0219205404683983,-0.0746143129476358,0.0113142056884854,0.148791751482856
CR2,Complement receptor type 2,Health and medical history,X2734.Number of live births,52246,-0.0457252641285099,0.0210249678617328,-0.0869342011375062,-0.00451632711951354,0.0296529278295572
CR2,Complement receptor type 2,Health and medical history,X2744.Birth weight of first child,46483,-0.0492942377350723,0.0234377345031435,-0.0952321973612337,-0.00335627810891098,0.0354596256931166
CR2,Complement receptor type 2,Health and medical history,X2754.Age at first live birth,43236,0.0109114015610868,0.00403120169636054,0.00301024623622012,0.0188125568859534,0.00680095258108289
CR2,Complement receptor type 2,Health and medical history,X2764.Age at last live birth,43181,0.00251443348211321,0.00388463738709759,-0.00509945579659806,0.0101283227608245,0.517461109279228
CR2,Complement receptor type 2,Health and medical history,X2794.Age started oral contraceptive pill,45772,0.0226979187247395,0.00437801861149855,0.0141170022462023,0.0312788352032766,2.18550310827667e-07
CR2,Complement receptor type 2,Health and medical history,X2804.Age when last used oral contraceptive pill,43782,-0.00949186540135136,0.00379378842566813,-0.0169276907156609,-0.00205604008704183,0.0123593655949444
CR2,Complement receptor type 2,Lifestyle factors,X2867.Age started smoking in former smokers,30106,0.00226929150020956,0.00743086643437979,-0.0122952067111748,0.016833789711594,0.760082510588141
CR2,Complement receptor type 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35609,0.0330658163768084,0.0390879876031991,-0.0435466393254618,0.109678272079079,0.397608299117359
CR2,Complement receptor type 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35601,-0.00521526381763247,0.042532197830953,-0.0885783715663004,0.0781478439310354,0.902410865026346
CR2,Complement receptor type 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35637,0.00805893906932656,0.0464911094110926,-0.083063635376415,0.0991815135150681,0.86238444458025
CR2,Complement receptor type 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35593,0.029180735600178,0.0444384648601572,-0.0579186555257301,0.116280126726086,0.511416406489499
CR2,Complement receptor type 2,Mental health,X28739.Difficulty with standing for long periods,35648,0.0566614163583256,0.0392517216192993,-0.020271958015501,0.133594790732152,0.148896498882477
CR2,Complement receptor type 2,Mental health,X28740.Difficulty with taking care of household responsibilities,35677,0.0070851226810225,0.042521951978857,-0.0762579031975372,0.0904281485595822,0.867669929007862
CR2,Complement receptor type 2,Mental health,X28741.Difficulty learning a new task,35569,0.0148862486571785,0.04718362782449,-0.0775936618788219,0.107366159193179,0.752390966100233
CR2,Complement receptor type 2,Mental health,X28742.Difficulty with joining in community activities,35286,-0.021814833138996,0.0500460953071329,-0.119905179940977,0.0762755136629845,0.66292173895375
CR2,Complement receptor type 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35600,-0.0113233965465285,0.0417466170266783,-0.093146765918818,0.0704999728257611,0.78621066037658
CR2,Complement receptor type 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35671,-0.0876540828256001,0.0617182452940692,-0.208621843601976,0.0333136779507755,0.155568625709544
CR2,Complement receptor type 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,30076,0.013437009063701,0.0481747507611763,-0.0809855024282047,0.107859520555607,0.780314762990805
CR2,Complement receptor type 2,Lifestyle factors,X2897.Age stopped smoking,30118,0.0126367387490712,0.00763093014040719,-0.0023198843261269,0.0275933618242693,0.0977793481790887
CR2,Complement receptor type 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34518,-0.00819505336670778,0.0104270175810192,-0.0286320078255054,0.0122419010920898,0.431918713468348
CR2,Complement receptor type 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34518,0.0125747429776933,0.0111082974904438,-0.00919752010357658,0.0343470060589632,0.257655714736415
CR2,Complement receptor type 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34518,-0.0254652380584025,0.0371559668379592,-0.0982909330608026,0.0473604569439976,0.493132142807234
CR2,Complement receptor type 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34518,-0.0244455220548951,0.0390015399705579,-0.100888540397189,0.0519974962873984,0.53081536971702
CR2,Complement receptor type 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34518,0.032738003855563,0.0412159862191216,-0.0480453291339153,0.113521336845041,0.427037467700119
CR2,Complement receptor type 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34518,0.0283806328878576,0.0339202622310894,-0.0381030810850777,0.0948643468607928,0.402788548798637
CR2,Complement receptor type 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34518,-0.0101037987711445,0.0157469133766347,-0.0409677489893484,0.0207601514470595,0.521123657034308
CR2,Complement receptor type 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34518,0.00453919616316802,0.027763642275197,-0.049877542696218,0.0589559350225541,0.870132574045621
CR2,Complement receptor type 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34446,-0.072138476044374,0.0474531808955519,-0.165146710599656,0.0208697585109078,0.128491561940798
CR2,Complement receptor type 2,Mental health,X29003.Recent feelings of depression,34428,-0.0218538175637811,0.0451388889726067,-0.11032603995009,0.066618404822528,0.6282928083611
CR2,Complement receptor type 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34448,-0.0440096205067674,0.0370935752839522,-0.116713028063314,0.0286937870497789,0.235473391691631
CR2,Complement receptor type 2,Mental health,X29005.Recent feelings of tiredness or low energy,34456,-0.00305483657571593,0.0376519146790076,-0.0768525893465709,0.070742916195139,0.935337303007021
CR2,Complement receptor type 2,Mental health,X29006.Recent poor appetite or overeating,34462,-0.000467257107609848,0.0487608469180109,-0.0960385170669113,0.0951040028516916,0.992354476251541
CR2,Complement receptor type 2,Mental health,X29007.Recent feelings of inadequacy,34418,0.0301212441916275,0.0488543053843933,-0.0656331943617834,0.125875682745038,0.53754401824743
CR2,Complement receptor type 2,Mental health,X29008.Recent trouble concentrating on things,34463,-0.0672536565837656,0.0494711215360792,-0.164217054794481,0.0297097416269496,0.174033763216435
CR2,Complement receptor type 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34449,0.00427551603481514,0.0879081145404535,-0.168024388464474,0.176575420534104,0.961210197922487
CR2,Complement receptor type 2,Mental health,X29010.Recent thoughts of suicide or self-harm,34386,0.0979618147220074,0.0986682416454463,-0.0954279389030674,0.291351568347082,0.320811934226218
CR2,Complement receptor type 2,Mental health,X29038#0.Substances taken for depression_None of options listed,33138,0.0502546816152701,0.0203881469467061,0.0102939135997262,0.0902154496308141,0.0137244705277381
CR2,Complement receptor type 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),33138,-0.116567450713746,0.0413837320320719,-0.197679565496607,-0.0354553359308855,0.00486223699126137
CR2,Complement receptor type 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),33138,-0.00565408429935688,0.0192071151058044,-0.0433000299067336,0.0319918613080198,0.768478808706805
CR2,Complement receptor type 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),33138,-0.0520694813250018,0.0559335462921491,-0.161699232057614,0.0575602694076103,0.351922444113236
CR2,Complement receptor type 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),33138,-0.0471847536716205,0.0353114246907142,-0.11639514606542,0.0220256387221793,0.181503850217624
CR2,Complement receptor type 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),33138,-0.0750683439502798,0.0368982042090387,-0.147388824199996,-0.00274786370056404,0.0419343952787548
CR2,Complement receptor type 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),33138,0.0467671000448357,0.0421261825915542,-0.0358002178346105,0.129334417924282,0.266957778839618
CR2,Complement receptor type 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),33138,-0.0326212697538286,0.0497890620598574,-0.130207831391149,0.0649652918834919,0.512363116472848
CR2,Complement receptor type 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),33138,0.0415115360515707,0.0370503440688256,-0.0311071383233275,0.114130210426469,0.262570521963337
CR2,Complement receptor type 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,33138,0.0221571191015512,0.0205804180898234,-0.0181805003545026,0.062494738557605,0.281683671668524
CR2,Complement receptor type 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,33138,0.00507839522421431,0.0309927631696651,-0.0556674205883292,0.0658242110367578,0.869847174531046
CR2,Complement receptor type 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,33138,-0.1044478167018,0.0485381469475244,-0.199582584718948,-0.00931304868465242,0.0314350152814274
CR2,Complement receptor type 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,33138,-0.147366938107203,0.0656519293751824,-0.276044719682561,-0.0186891565318456,0.0248143708689187
CR2,Complement receptor type 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,33138,-0.130927786907907,0.0415869333428848,-0.212438176259961,-0.049417397555853,0.00164783940686088
CR2,Complement receptor type 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,33138,-0.0600791323179777,0.070852152375213,-0.198949350973395,0.0787910863374399,0.396488791388317
CR2,Complement receptor type 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,33138,-0.062700265514783,0.0677970936972918,-0.195582569161475,0.070182038131909,0.355084030019954
CR2,Complement receptor type 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,33138,-0.0912748596826023,0.0356308618961709,-0.161111348999097,-0.0214383703661074,0.010433456943086
CR2,Complement receptor type 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,33138,-0.0325960185099442,0.0351185399334996,-0.101428356779603,0.036236319759715,0.353344544974008
CR2,Complement receptor type 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,33138,0.016482151090258,0.0485571116920298,-0.0786897878261205,0.111654090006636,0.734287658009023
CR2,Complement receptor type 2,Mental health,X29058.Recent feelings or nervousness or anxiety,34304,0.0941128164432913,0.0417038667798105,0.0123732375548628,0.17585239533172,0.0240490996162968
CR2,Complement receptor type 2,Mental health,X29059.Recent inability to stop or control worrying,34316,0.0249050756496171,0.0429729463573823,-0.0593218992108522,0.109132050510086,0.562229715958724
CR2,Complement receptor type 2,Mental health,X29060.Recent worrying too much about different things,34309,0.0170700119882127,0.0403913970137903,-0.0620971261588163,0.0962371501352417,0.672585369673234
CR2,Complement receptor type 2,Mental health,X29061.Recent trouble relaxing,34314,-0.00223643387608055,0.0426453384111621,-0.0858212971619582,0.0813484294097971,0.958177066153241
CR2,Complement receptor type 2,Mental health,X29062.Recent restlessness,34327,-0.107788259273911,0.0619848341053432,-0.229278534120384,0.0137020155725617,0.0820754882403938
CR2,Complement receptor type 2,Mental health,X29063.Recent easy annoyance or irritability,34291,0.000805827118932765,0.0447162744949298,-0.0868380708911296,0.0884497251289952,0.98562255279998
CR2,Complement receptor type 2,Mental health,X29064.Recent feelings of foreboding,34281,-0.058864258907977,0.0484046977255891,-0.153737466450132,0.0360089486341776,0.223981501668936
CR2,Complement receptor type 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,33138,0.00841207670148353,0.020112803720379,-0.0310090185904593,0.0478331719934264,0.675778442454572
CR2,Complement receptor type 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,33138,0.0103397834601665,0.0352576523894404,-0.0587652152231367,0.0794447821434697,0.769327736541739
CR2,Complement receptor type 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',33138,0.0480782575791588,0.0439835013211856,-0.0381294050103649,0.134285920168682,0.274381285768752
CR2,Complement receptor type 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,33138,0.107902011922474,0.0477201293922449,0.0143705583136741,0.201433465531274,0.0237750655052359
CR2,Complement receptor type 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,33138,0.0324025368098067,0.033027991370193,-0.0323323262757716,0.097137399895385,0.32658905143309
CR2,Complement receptor type 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,33138,-0.0130736433231907,0.0326293601217511,-0.0770271891618228,0.0508799025154414,0.68867210698652
CR2,Complement receptor type 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,33138,0.00906130798070839,0.0334369287023291,-0.0564750722758567,0.0745976882372735,0.786399764953922
CR2,Complement receptor type 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,33138,-0.010873910025755,0.0300127455534355,-0.0696988913104886,0.0479510712589785,0.717129395197383
CR2,Complement receptor type 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,33138,0.0442064099813063,0.040916789882244,-0.0359904981878919,0.124403318150505,0.279995069604234
CR2,Complement receptor type 2,Mental health,X29076.Felt loved as a child,34282,0.00330241572914805,0.0395243411397918,-0.0741652929048438,0.0807701243631399,0.933412765067806
CR2,Complement receptor type 2,Mental health,X29077.Physically abused by family as a child,34295,0.00106373867375932,0.0550052300536655,-0.106746512231425,0.108873989578944,0.984571172673675
CR2,Complement receptor type 2,Mental health,X29078.Felt hated by family member as a child,34274,-0.0797495898766764,0.0513609844476273,-0.180417119394026,0.0209179396406731,0.120520585845857
CR2,Complement receptor type 2,Mental health,X29079.Sexually molested as a child,34165,-0.158489387734472,0.0651982134928923,-0.286277886180541,-0.0307008892884033,0.0150799557033821
CR2,Complement receptor type 2,Mental health,X29080.Someone to take to doctor when needed as a child,34252,-0.0828647476905305,0.055488057441735,-0.191621340276331,0.0258918448952701,0.135369983765405
CR2,Complement receptor type 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34276,-0.133231423972473,0.0678019157745138,-0.26612317889052,-0.000339669054425978,0.0494412505382344
CR2,Complement receptor type 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34195,-0.0797220811309759,0.0515364415961748,-0.180733506659479,0.0212893443975267,0.121918160401964
CR2,Complement receptor type 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34277,-0.135187291043353,0.0576360500037934,-0.248153949050788,-0.0222206330359177,0.0190196491611627
CR2,Complement receptor type 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34234,-0.120909162078114,0.0707177688644857,-0.259515989052506,0.017697664896278,0.0873452511857782
CR2,Complement receptor type 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34241,-0.106539497207101,0.0707251784810593,-0.245160847029977,0.0320818526157755,0.132000098202892
CR2,Complement receptor type 2,Mental health,X29086.Experienced a violent or sexual assault,34272,-0.0604958481187133,0.0662559281881762,-0.190357467367539,0.069365771130112,0.361231734711314
CR2,Complement receptor type 2,Mental health,X29087.Experienced a life-threatening injury or illness,34284,-0.0136846976076984,0.0474352525703483,-0.106657792645581,0.0792883974301843,0.772976127085428
CR2,Complement receptor type 2,Mental health,X29088.Experienced a marital separation or divorce,34291,-0.108466944013497,0.0420864570825156,-0.190956399895228,-0.0259774881317668,0.00997367368981205
CR2,Complement receptor type 2,Mental health,X29089.Experienced the death of a spouse or partner,34300,-0.0179513197433845,0.0533142762615344,-0.122447301215992,0.0865446617292229,0.736344540989252
CR2,Complement receptor type 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34282,0.0465164487717859,0.0534025938949951,-0.0581526352624046,0.151185532805976,0.383746906630662
CR2,Complement receptor type 2,Lifestyle factors,X29091.Frequency of drinking alcohol,34297,-0.307127562151722,0.0353860416114994,-0.376484203710261,-0.237770920593184,4.61193983104498e-18
CR2,Complement receptor type 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33030,-0.201982241528861,0.0434971752106102,-0.287236704941657,-0.116727778116065,3.47531893087564e-06
CR2,Complement receptor type 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33047,-0.24358137730663,0.0446866765262235,-0.331167263298028,-0.155995491315232,5.15120984542497e-08
CR2,Complement receptor type 2,Mental health,X29104.Ever used cannabis,34290,-0.0580660805968996,0.0535635473142636,-0.163050633332856,0.046918472139057,0.27836492374113
CR2,Complement receptor type 2,Mental health,X29108.Ever thought that life not worth living,34234,-0.0103270016173564,0.0428933790586134,-0.0943980245722386,0.0737440213375259,0.809746329707906
CR2,Complement receptor type 2,Mental health,X29109.Ever contemplated self-harm,34272,-0.00333836466444509,0.0568095780800509,-0.114685137701345,0.108008408372455,0.953141185755993
CR2,Complement receptor type 2,Mental health,X29111.Ever self-harmed,34286,0.0425319651870686,0.0877617030401314,-0.129480972771589,0.214544903145726,0.627949534770591
CR2,Complement receptor type 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34279,-0.0685480603264772,0.0596850118532932,-0.185530683558932,0.0484345629059775,0.250791386011863
CR2,Complement receptor type 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33861,0.0109069113387072,0.0439363632434436,-0.0752083606184423,0.0970221832958567,0.803951521252622
CR2,Complement receptor type 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33861,-0.0139146881873184,0.0336782835478162,-0.0799241239410381,0.0520947475664013,0.679495140914589
CR2,Complement receptor type 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33861,-0.00351686993519006,0.0340572979069697,-0.0702691738328507,0.0632354339624706,0.917756180486579
CR2,Complement receptor type 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33861,0.0391811747257759,0.0440103524992902,-0.0470791161728328,0.125441465624385,0.373342734299247
CR2,Complement receptor type 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34273,-0.0342968293854621,0.0393680509822198,-0.111458209310613,0.0428645505396887,0.383674807834816
CR2,Complement receptor type 2,Health and medical history,X29153.Pain or discomfort today,34285,-0.0151336022181584,0.0377681052700766,-0.0891590885475085,0.0588918841111917,0.688651231418443
CR2,Complement receptor type 2,Mental health,X29154.Anxiety or depression today,34285,0.0558476717003007,0.0453746247741291,-0.0330865928569924,0.144781936257594,0.218422313585758
CR2,Complement receptor type 2,Mental health,X29166.Frequency of confiding in someone close,34038,0.00207107352598615,0.0367919004786039,-0.0700410514120774,0.0741831984640497,0.955110714852816
CR2,Complement receptor type 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34250,0.0127202550722915,0.0111798879256181,-0.00919232526191998,0.034632835406503,0.255240097935346
CR2,Complement receptor type 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34250,-0.0266765266029241,0.0109637583914621,-0.0481654930501897,-0.00518756015565839,0.0149856452223468
CR2,Complement receptor type 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34250,-0.0494304566326929,0.0159843698017548,-0.0807598214441322,-0.0181010918212536,0.0019908665427992
CR2,Complement receptor type 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34250,0.0337945064693487,0.0140062368977117,0.00634228214983364,0.0612467307888637,0.0158479457416762
CR2,Complement receptor type 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34250,-0.0391628607931493,0.0208321870920749,-0.0799939474936162,0.00166822590731752,0.0601485251897913
CR2,Complement receptor type 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34250,-0.00439279334457846,0.0109789093713322,-0.0259114557123896,0.0171258690232327,0.689082751529383
CR2,Complement receptor type 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34252,0.00420625325348793,0.0122086473407739,-0.0197226955344289,0.0281352020414048,0.730454639786117
CR2,Complement receptor type 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34252,-0.0234942912245635,0.0170826347046194,-0.0569762552456176,0.00998767279649054,0.169060029899226
CR2,Complement receptor type 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34252,-0.107666708501648,0.0354613199133661,-0.177170895531845,-0.0381625214714501,0.00240231107097854
CR2,Complement receptor type 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34252,0.0524434968613095,0.0235266655618988,0.00633123235998787,0.0985557613626311,0.0258292486875382
CR2,Complement receptor type 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34252,-0.0352820008418554,0.0331867396274845,-0.100328010511725,0.0297640088280143,0.287746705774495
CR2,Complement receptor type 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34252,0.00317885880685461,0.0173929477381128,-0.0309113187598464,0.0372690363735556,0.854984536268356
CR2,Complement receptor type 2,Mental health,X29171.Frequency of feeling 'in tune' with people,34138,-0.0377113226480788,0.045858645609019,-0.127594268041756,0.0521716227455983,0.410904604768166
CR2,Complement receptor type 2,Mental health,X29172.Freuency of feeling that lacks companionship,34225,0.0724532568874994,0.0408384238520958,-0.00759005386260833,0.152496567637607,0.0760704158113685
CR2,Complement receptor type 2,Mental health,X29173.Frequency of feeling left out,34163,0.024599205078205,0.0426501017746984,-0.0589949944002038,0.108193404556614,0.564109699207532
CR2,Complement receptor type 2,Mental health,X29174.Frequency of feeling isolated from others,34197,-0.0175467160949903,0.0442415742926172,-0.10426020170852,0.0691667695185395,0.691662673762598
CR2,Complement receptor type 2,Mental health,X29175.Tendency to bounce back quickly after hard times,34270,-0.00141497438805916,0.0373220930760454,-0.0745662768171081,0.0717363280409898,0.969758206284588
CR2,Complement receptor type 2,Mental health,X29176.Ability to make it through stressful events,34270,0.0409466018458241,0.0362473334188623,-0.0300981716551461,0.111991375346794,0.258653646645489
CR2,Complement receptor type 2,Mental health,X29177.Quick recovery from stressful events,34270,-0.0632975617149139,0.0366526334409069,-0.135136723259091,0.0085415998292636,0.0842066539983822
CR2,Complement receptor type 2,Mental health,X29178.Hard to snap back when something bad happens,34270,0.0651686069511247,0.0361759299373859,-0.00573621572615172,0.136073429628401,0.0716649321017609
CR2,Complement receptor type 2,Mental health,X29179.Comes through difficult times with little trouble,34270,-0.0293962917271051,0.0365338571401689,-0.101002651721836,0.042210068267626,0.421051856965491
CR2,Complement receptor type 2,Mental health,X29180.Tendency to take a long time to get over setbacks,34270,0.0470512957716745,0.0362834480953694,-0.0240642624952495,0.118166854038599,0.194740737040136
CR2,Complement receptor type 2,Mental health,X29181.General happiness,34210,-0.0229487913138319,0.0380178790929627,-0.0974638343360388,0.051566251708375,0.546102668467421
CR2,Complement receptor type 2,Mental health,X29182.Belief that own life is meaningful,34114,0.0382050010032794,0.0374252700408634,-0.0351485282768128,0.111558530283372,0.307358496716026
CR2,Complement receptor type 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29650,-0.0257410751481642,0.0485612521086063,-0.120921129281033,0.0694389789847041,0.596083013366839
CR2,Complement receptor type 2,Health and medical history,X2946.Father's age,30726,-0.0168816534444906,0.00978252037391272,-0.0360553933773595,0.0022920864883783,0.0844514077903768
CR2,Complement receptor type 2,Health and medical history,X2966.Age high blood pressure diagnosed,30385,-0.00804190186166959,0.00813370179091669,-0.0239839573718663,0.00790015364852712,0.322843589213008
CR2,Complement receptor type 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51340,-0.0152168507752998,0.00334725921306745,-0.021777478832912,-0.00865622271768759,5.48968207005753e-06
CR2,Complement receptor type 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51340,0.079283222258777,0.00389680077689456,0.0716454927360637,0.0869209517814904,2.47112037467668e-91
CR2,Complement receptor type 2,Blood and urine assays,X30020.Haemoglobin concentration,51340,0.0416581671513409,0.00425386460707096,0.0333205925214818,0.0499957417812,1.31618778639465e-22
CR2,Complement receptor type 2,Blood and urine assays,X30030.Haematocrit percentage,51340,0.04046292088334,0.00412608407896875,0.0323757960885612,0.0485500456781187,1.15095377680349e-22
CR2,Complement receptor type 2,Blood and urine assays,X30040.Mean corpuscular volume,51340,-0.0605847214239668,0.00327175481530314,-0.0669973608619609,-0.0541720819859726,4.43931822353731e-76
CR2,Complement receptor type 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51339,-0.0533806669654408,0.00328187904973264,-0.0598131499029168,-0.0469481840279648,3.33943174196554e-59
CR2,Complement receptor type 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51339,-0.000391095585139992,0.00322772227389172,-0.00671743124196777,0.00593524007168779,0.90355913699645
CR2,Complement receptor type 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51340,0.000293480324231061,0.0031137168178325,-0.00580940463872063,0.00639636528718275,0.924908077048972
CR2,Complement receptor type 2,Blood and urine assays,X30080.Platelet count,51340,-0.045424463108089,0.00328872174006599,-0.0518703577186183,-0.0389785684975596,3.02412902667304e-43
CR2,Complement receptor type 2,Blood and urine assays,X30090.Platelet crit,51340,-0.0464204625752431,0.00336859209007891,-0.0530229030717978,-0.0398180220786884,4.68697912643721e-43
CR2,Complement receptor type 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51340,0.0118301501117282,0.00319671798253058,0.00556458286596821,0.0180957173574881,0.000215419457140323
CR2,Complement receptor type 2,Blood and urine assays,X30110.Platelet distribution width,51340,0.03472866329283,0.00318373710794065,0.0284885385612663,0.0409687880243937,1.20431226639965e-27
CR2,Complement receptor type 2,Blood and urine assays,X30120.Lymphocyte count,51302,-0.00165563011276746,0.00332749307177558,-0.0081775165334476,0.00486625630791268,0.6187977140304
CR2,Complement receptor type 2,Blood and urine assays,X30130.Monocyte count,51302,-0.00543537176232688,0.00337800480420404,-0.0120562611785668,0.00118551765391305,0.107617610049134
CR2,Complement receptor type 2,Blood and urine assays,X30140.Neutrophill count,51302,-0.0186031368669358,0.00332422246843643,-0.0251186129050712,-0.0120876608288004,2.21189482807169e-08
CR2,Complement receptor type 2,Blood and urine assays,X30150.Eosinophill count,51302,0.0350181996036861,0.00326822263822161,0.0286124832327717,0.0414239159746004,9.82946551047683e-27
CR2,Complement receptor type 2,Blood and urine assays,X30160.Basophill count,51302,-0.0441587688985812,0.0238845249926794,-0.0909724378842329,0.0026549000870705,0.0644912785347815
CR2,Complement receptor type 2,Blood and urine assays,X30170.Nucleated red blood cell count,51302,0.0959849243382448,0.105655787927982,-0.1111004200006,0.30307026867709,0.363639057343884
CR2,Complement receptor type 2,Blood and urine assays,X30180.Lymphocyte percentage,51302,0.00963949806624638,0.00328960600485317,0.00319187029673417,0.0160871258357586,0.00338931436185722
CR2,Complement receptor type 2,Blood and urine assays,X30190.Monocyte percentage,51302,0.00517838415065016,0.00333112966291741,-0.00135062998866798,0.0117073982899683,0.120066744868627
CR2,Complement receptor type 2,Blood and urine assays,X30200.Neutrophill percentage,51302,-0.0158031739258631,0.00325900190332766,-0.0221908176563853,-0.00941553019534086,1.24726408127061e-06
CR2,Complement receptor type 2,Blood and urine assays,X30210.Eosinophill percentage,51302,0.0416120142309582,0.00322944186806211,0.0352823081695565,0.04794172029236,7.06307458357497e-38
CR2,Complement receptor type 2,Blood and urine assays,X30220.Basophill percentage,51302,-0.00486439633940951,0.00309880862959413,-0.010938061253414,0.00120926857459498,0.116481951302286
CR2,Complement receptor type 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51302,0.099217585382606,0.10564377037447,-0.107844204551355,0.306279375316568,0.347651307669427
CR2,Complement receptor type 2,Blood and urine assays,X30240.Reticulocyte percentage,50855,0.00451001713797283,0.00339546566271947,-0.00214509556095732,0.011165129836903,0.184107997585832
CR2,Complement receptor type 2,Blood and urine assays,X30250.Reticulocyte count,50855,0.0189943099062324,0.00350704560275566,0.0121205005248313,0.0258681192876335,6.14641945159945e-08
CR2,Complement receptor type 2,Blood and urine assays,X30260.Mean reticulocyte volume,50855,-0.0293399126090173,0.00325615475754818,-0.0357219759338117,-0.0229578492842228,2.18433613426042e-19
CR2,Complement receptor type 2,Blood and urine assays,X30270.Mean sphered cell volume,50855,-0.057646206116942,0.00327305859704071,-0.0640614009671418,-0.0512310112667422,4.92061999138228e-69
CR2,Complement receptor type 2,Blood and urine assays,X30280.Immature reticulocyte fraction,50855,-0.0183336357722893,0.00343258513892638,-0.025061502644585,-0.0116057688999936,9.31696273544897e-08
CR2,Complement receptor type 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50855,-0.00444353337769409,0.00348954012628894,-0.0112830320252204,0.00239596526983223,0.202892126939476
CR2,Complement receptor type 2,Blood and urine assays,X30300.High light scatter reticulocyte count,50855,0.00703525429537718,0.00357919734030446,2.00275083804321e-05,0.0140504810823739,0.0493558153204701
CR2,Complement receptor type 2,Blood and urine assays,X30500.Microalbumin in urine,32193,0.00122711929715318,0.00633183501901073,-0.0111832773401079,0.0136375159344142,0.846336376080269
CR2,Complement receptor type 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51389,-0.0147587816686531,0.00339977662184709,-0.0214223438474734,-0.00809521948983284,1.42285673124161e-05
CR2,Complement receptor type 2,Blood and urine assays,X30520.Potassium in urine,51335,-0.00716013018812014,0.00316369634706504,-0.0133609750283676,-0.000959285347872654,0.0236302780039482
CR2,Complement receptor type 2,Blood and urine assays,X30530.Sodium in urine,51306,-0.00808885798682213,0.0033332018902198,-0.0146219336916529,-0.00155578228199133,0.0152411557604807
CR2,Complement receptor type 2,Blood and urine assays,X30600.Albumin,48567,0.038269494751665,0.00349269990767365,0.0314238029326246,0.0451151865707053,7.15624560882236e-28
CR2,Complement receptor type 2,Blood and urine assays,X30610.Alkaline phosphatase,50949,0.0706300736677544,0.00330110894138273,0.0641599001426442,0.0771002471928646,1.0399829407763e-100
CR2,Complement receptor type 2,Blood and urine assays,X30620.Alanine aminotransferase,50957,0.0344579485505019,0.0034647685406021,0.0276670022109218,0.0412488948900821,2.90583496226509e-23
CR2,Complement receptor type 2,Blood and urine assays,X30630.Apolipoprotein A,48348,-0.071047988537947,0.00380800664813614,-0.0785116815682938,-0.0635842955076002,3.87784083597975e-77
CR2,Complement receptor type 2,Blood and urine assays,X30640.Apolipoprotein B,50850,-0.00456029210601155,0.00330615777442438,-0.0110403613438833,0.00191977713186024,0.167803829857787
CR2,Complement receptor type 2,Blood and urine assays,X30650.Aspartate aminotransferase,50876,0.0404171433534031,0.00334422685407701,0.0338624587194122,0.0469718279873941,1.54217425105147e-33
CR2,Complement receptor type 2,Blood and urine assays,X30660.Direct bilirubin,45077,0.0133992655770192,0.00376420449412298,0.00602142476853816,0.0207771063855002,0.000372178389756321
CR2,Complement receptor type 2,Blood and urine assays,X30670.Urea,50944,0.0273162729432784,0.00345378334611685,0.0205468575848894,0.0340856883016675,2.69336173361868e-15
CR2,Complement receptor type 2,Blood and urine assays,X30680.Calcium,48573,0.0257332576792279,0.00335539845942705,0.0191566766987509,0.0323098386597049,1.79582010076054e-14
CR2,Complement receptor type 2,Blood and urine assays,X30690.Cholesterol,50957,-0.016631166903818,0.00340209447942839,-0.0232992720834977,-0.00996306172413841,1.02196710548039e-06
CR2,Complement receptor type 2,Blood and urine assays,X30700.Creatinine,50951,0.0303464433656236,0.00376839642293019,0.0229603863766805,0.0377325003545668,8.42380065753185e-16
CR2,Complement receptor type 2,Blood and urine assays,X30710.C-reactive protein,50890,-0.0155033521251689,0.00364081597202248,-0.0226393514303329,-0.00836735282000484,2.06782966952328e-05
CR2,Complement receptor type 2,Blood and urine assays,X30720.Cystatin C,50954,0.0776517869315542,0.00367703634840556,0.0704447956886793,0.0848587781744291,3.50151460891398e-98
CR2,Complement receptor type 2,Blood and urine assays,X30730.Gamma glutamyltransferase,50953,0.0148451845259999,0.00340669057036345,0.00816807100808753,0.0215222980439122,1.3195710338878e-05
CR2,Complement receptor type 2,Blood and urine assays,X30740.Glucose,48546,0.0048891448693301,0.00362946051341804,-0.00222459773696926,0.0120028874756295,0.177969692881531
CR2,Complement receptor type 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50777,0.0237180720036172,0.00369537989724948,0.0164751274050083,0.0309610166022262,1.40145594525326e-10
CR2,Complement receptor type 2,Blood and urine assays,X30760.HDL cholesterol,48559,-0.069965751366615,0.00401242681019667,-0.0778301079146005,-0.0621013948186296,1.12014317339209e-67
CR2,Complement receptor type 2,Blood and urine assays,X30770.IGF-1,50807,0.0273793478451853,0.00332308473028685,0.0208661017738231,0.0338925939165475,1.81426843290699e-16
CR2,Complement receptor type 2,Blood and urine assays,X30780.LDL direct,50901,-0.000524957478791044,0.00331824827812279,-0.0070287241039117,0.00597880914632962,0.87429789413208
CR2,Complement receptor type 2,Blood and urine assays,X30790.Lipoprotein A,45667,-0.000644916944967904,0.00363532208942318,-0.00777014824023733,0.00648031435030152,0.859193566196832
CR2,Complement receptor type 2,Blood and urine assays,X30810.Phosphate,48525,0.0279397450467976,0.00361265256788499,0.020858946013743,0.0350205440798522,1.08410759810997e-14
CR2,Complement receptor type 2,Blood and urine assays,X30830.SHBG,48300,-0.0254384998420718,0.00380066323784747,-0.0328877997882528,-0.0179891998958907,2.23226043939053e-11
CR2,Complement receptor type 2,Blood and urine assays,X30840.Total bilirubin,50860,0.0251137570345857,0.00333658608777643,0.0185740483025439,0.0316534657666275,5.366506858171e-14
CR2,Complement receptor type 2,Blood and urine assays,X30850.Testosterone,46428,-0.00980276961818741,0.00585143232927365,-0.0212715769835638,0.00166603774718894,0.0938941356933417
CR2,Complement receptor type 2,Blood and urine assays,X30860.Total protein,48565,0.036943669578825,0.00340669140567152,0.0302665544237088,0.0436207847339411,2.45077321130793e-27
CR2,Complement receptor type 2,Blood and urine assays,X30870.Triglycerides,50948,0.0136643420153084,0.00369074362110136,0.00643048451794978,0.0208981995126671,0.000214063537246586
CR2,Complement receptor type 2,Blood and urine assays,X30880.Urate,50919,0.02638668207347,0.00405604107182551,0.018436841572692,0.034336522574248,7.88037107350975e-11
CR2,Complement receptor type 2,Blood and urine assays,X30890.Vitamin D,49408,0.000460588325678682,0.00364229105284246,-0.00667830213789254,0.00759947878924991,0.899372262687809
CR2,Complement receptor type 2,Physical measures,X3137.Number of measurements made,49816,0.0288138676298547,0.0268809060687081,-0.0238727082648131,0.0815004435245226,0.283771399281256
CR2,Complement receptor type 2,Physical measures,X3143.Ankle spacing width,40248,0.0229909964988166,0.00562704193662984,0.0119619943030221,0.034019998694611,4.41411090319036e-05
CR2,Complement receptor type 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40247,-0.010786181640616,0.00456825760166225,-0.019739966539874,-0.00183239674135798,0.0182321523777886
CR2,Complement receptor type 2,Physical measures,X3146.Speed of sound through heel,40248,-0.0112924876141755,0.00440176394005338,-0.0199199449366802,-0.0026650302916709,0.0103134712127395
CR2,Complement receptor type 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40248,-0.0117424475755636,0.00445805319753929,-0.0204802318427406,-0.00300466330838657,0.00844713485407386
CR2,Complement receptor type 2,Physical measures,X3148.Heel bone mineral density (BMD),40246,-0.0118295816614622,0.0044466867943883,-0.0205450877784633,-0.00311407554446113,0.00781467724493207
CR2,Complement receptor type 2,Health and medical history,X3526.Mother's age at death,40974,-0.00391008826693811,0.00427937238965421,-0.0122976581506604,0.00447748161678414,0.360884678898662
CR2,Complement receptor type 2,Health and medical history,X3581.Age at menopause (last menstrual period),40329,0.00623032470106615,0.00424142252998278,-0.0020828634577001,0.0145435128598324,0.141873385777958
CR2,Complement receptor type 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30179,0.000961778942408011,0.00720101756636072,-0.013152215487659,0.015075773372475,0.893753996897385
CR2,Complement receptor type 2,Physical measures,X4100.Ankle spacing width (left),33371,0.01269935477876,0.00757923635320789,-0.00215594847352746,0.0275546580310475,0.0938623194622469
CR2,Complement receptor type 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33369,0.000978853501055616,0.00621608604860353,-0.0112046751542073,0.0131623821563185,0.874877199541995
CR2,Complement receptor type 2,Physical measures,X4103.Speed of sound through heel (left),33371,0.00304724126671119,0.00605377308975365,-0.00881815398920597,0.0149126365226283,0.614721989130788
CR2,Complement receptor type 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33371,0.00194718485895795,0.00610716974008858,-0.0100228678316157,0.0139172375495316,0.749858432363697
CR2,Complement receptor type 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),33369,0.00185356156649684,0.00608968878461347,-0.0100822284513456,0.0137893515843392,0.760847745711229
CR2,Complement receptor type 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33371,0.0019641447873774,0.00610682237460241,-0.0100052270668433,0.0139335166415981,0.747739619487018
CR2,Complement receptor type 2,Physical measures,X4119.Ankle spacing width (right),33374,0.0143837744681537,0.00748995167161622,-0.000296530808214108,0.0290640797445215,0.0548380328188467
CR2,Complement receptor type 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33374,0.00129685401674899,0.00622472244337463,-0.0109036019722653,0.0134973100057633,0.834968841109988
CR2,Complement receptor type 2,Physical measures,X4122.Speed of sound through heel (right),33374,0.00484446125973137,0.00607667585727025,-0.00706582342051831,0.0167547459399811,0.425343175291482
CR2,Complement receptor type 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33374,0.0034890263094702,0.0061238911742072,-0.00851380039197591,0.0154918530109163,0.56886833918052
CR2,Complement receptor type 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),33371,0.00391706142404211,0.0061116971091901,-0.00806186490997049,0.0158959877580547,0.521596176301254
CR2,Complement receptor type 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33374,0.00348952294241129,0.00612390398391758,-0.00851332886606718,0.0154923747508897,0.568814138811078
CR2,Complement receptor type 2,Physical measures,X4194.Pulse rate,33633,-0.00421917881917206,0.00592651771365822,-0.0158351535379422,0.00739679589959805,0.476535297123017
CR2,Complement receptor type 2,Physical measures,X4195.Pulse wave reflection index,33633,0.00326242381907097,0.00593439672966129,-0.00836899377106515,0.0148938414092071,0.582505476008134
CR2,Complement receptor type 2,Physical measures,X4196.Pulse wave peak to peak time,33630,-0.00612289641072369,0.0054218479641782,-0.016749718420513,0.00450392559906559,0.258800543079038
CR2,Complement receptor type 2,Physical measures,X4198.Position of the pulse wave peak,33633,0.0032631442102243,0.00524881562625411,-0.00702453441723375,0.0135508228376823,0.534160159554713
CR2,Complement receptor type 2,Physical measures,X4199.Position of pulse wave notch,33633,-0.0026343678584983,0.00585436389921332,-0.0141089211009564,0.00884018538395981,0.652732875745816
CR2,Complement receptor type 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33633,0.00236970472120275,0.00524545872511264,-0.00791139438001803,0.0126508038224235,0.651450323325112
CR2,Complement receptor type 2,Physical measures,X4269.Number of triplets attempted (left),33540,0.0596471176958376,0.116404896595141,-0.168506479630639,0.287800715022314,0.608376056868573
CR2,Complement receptor type 2,Physical measures,X4270.Volume level set by participant (left),33452,0.00753600633027359,0.0369101509812771,-0.0648078895930295,0.0798799022535767,0.83822398481536
CR2,Complement receptor type 2,Physical measures,X4276.Number of triplets attempted (right),33537,-0.0624799180336753,0.111593708894977,-0.281203587467829,0.156243751400479,0.575570027480919
CR2,Complement receptor type 2,Physical measures,X4277.Volume level set by participant (right),33428,0.031289305936408,0.0366655785417724,-0.0405752280054659,0.103153839878282,0.393476913962657
CR2,Complement receptor type 2,Cognitive function,X4288.Time to answer,33706,-0.00106977242426455,0.00664572061253782,-0.0140953848248387,0.0119558399763096,0.872119265547237
CR2,Complement receptor type 2,Cognitive function,X4290.Duration screen displayed,33706,0.00901017844303869,0.00590493122388831,-0.0025634867557824,0.0205838436418598,0.127075530232029
CR2,Complement receptor type 2,Physical measures,X46.Hand grip strength (left),52162,-0.0168750266784746,0.00481218546056366,-0.0263069101811794,-0.00744314317576985,0.000454369705713264
CR2,Complement receptor type 2,Physical measures,X47.Hand grip strength (right),52169,-0.0152643956016953,0.00479554434604771,-0.0246636625199488,-0.00586512868344175,0.00145899851735056
CR2,Complement receptor type 2,Physical measures,X48.Waist circumference,52253,0.00329654638942966,0.0064092642482198,-0.00926561153708116,0.0158587043159405,0.60701779803633
CR2,Complement receptor type 2,Health and medical history,X4803.Tinnitus,33546,0.0532895320878804,0.0444138083957416,-0.0337615323677732,0.140340596543534,0.230232156695476
CR2,Complement receptor type 2,Working and living environment,X4825.Noisy workplace,33683,-0.031583634780805,0.0641574145674996,-0.157332167333104,0.0941648977714941,0.622530672626378
CR2,Complement receptor type 2,Working and living environment,X4836.Loud music exposure frequency,33626,-0.115188940192742,0.0742986564949878,-0.260814306922918,0.0304364265374344,0.121091975922919
CR2,Complement receptor type 2,Physical measures,X49.Hip circumference,52250,0.00166015115621417,0.00543351688369843,-0.00898954193583475,0.0123098442482631,0.759957981472414
CR2,Complement receptor type 2,Physical measures,X50.Standing height,52248,0.0198159647358896,0.00444974199156211,0.0110944704324278,0.0285374590393513,8.489604494597e-06
CR2,Complement receptor type 2,Health and medical history,X5057.Number of older siblings,32603,-0.00762428759726384,0.0391944974364246,-0.0844455025726562,0.0691969273781285,0.845770110663246
CR2,Complement receptor type 2,Physical measures,X51.Seated height,52121,0.0166570364394124,0.00447162842674149,0.00789264472299911,0.0254214281558258,0.000195664884965155
CR2,Complement receptor type 2,Eye measures,X5181.Ever had eye surgery,30677,0.0370747267289054,0.0883782419763544,-0.136146627544749,0.21029608100256,0.674864787129814
CR2,Complement receptor type 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30660,0.00534193045213572,0.00684869181984884,-0.00808150551476801,0.0187653664190395,0.435424837076863
CR2,Complement receptor type 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30663,0.00492384264646724,0.00675095582547337,-0.00830803077146057,0.018155716064395,0.465812106600016
CR2,Complement receptor type 2,Eye measures,X5190.Duration at which refractometer first shown (right),30589,0.00709916989717754,0.00679261878929651,-0.00621436292984362,0.0204127027241987,0.296004038582563
CR2,Complement receptor type 2,Eye measures,X5193.Duration at which refractometer first shown (left),30591,0.00110182640848965,0.00683923211279445,-0.0123030685325875,0.0145067213495668,0.872016934026625
CR2,Complement receptor type 2,Eye measures,"X5199.logMAR, initial (right)",30641,-0.0376514197298733,0.0468574734634472,-0.12949206771823,0.0541892282584832,0.421698908157497
CR2,Complement receptor type 2,Eye measures,X5200.Final number of letters displayed (right),30641,0.0728004212827031,0.337449017958597,-0.588599653916147,0.734200496481553,0.829199448465623
CR2,Complement receptor type 2,Eye measures,"X5201.logMAR, final (right)",30589,-0.00695770207413041,0.00712820391941345,-0.0209289817561808,0.00701357760791994,0.329062961052275
CR2,Complement receptor type 2,Eye measures,X5202.Number of rounds to result (right),30641,-0.0278226530871661,0.0439177161787886,-0.113901376797592,0.0582560706232595,0.526419039776971
CR2,Complement receptor type 2,Eye measures,"X5206.logMAR, initial (left)",30640,-0.0259420073351384,0.0466043197658948,-0.117286474076292,0.0654024594060153,0.577790929897437
CR2,Complement receptor type 2,Eye measures,X5207.Final number of letters displayed (left),30640,0.15010479609992,0.275448349690865,-0.389773969294175,0.689983561494015,0.585809504476112
CR2,Complement receptor type 2,Eye measures,"X5208.logMAR, final (left)",30576,-0.00272138448768612,0.00705380509052251,-0.0165468424651102,0.011104073489738,0.699655415594056
CR2,Complement receptor type 2,Eye measures,X5209.Number of rounds to result (left),30638,-0.0332343767845159,0.043903078246142,-0.119284410146954,0.0528156565779225,0.449082203041901
CR2,Complement receptor type 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30345,0.013467534357993,0.0069421676174493,-0.000139114172207588,0.0270741828881937,0.0524320808216807
CR2,Complement receptor type 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30345,0.0117817244570071,0.00700016783146347,-0.00193860449266135,0.0255020534066755,0.0924158391123822
CR2,Complement receptor type 2,Eye measures,X5256.Corneal hysteresis (right),30345,-0.00338139555516898,0.00694830564770979,-0.0170000746246802,0.0102372835143422,0.626524215620404
CR2,Complement receptor type 2,Eye measures,X5257.Corneal resistance factor (right),30345,0.00457516985248044,0.00696569288069018,-0.00907758819367231,0.0182279278986332,0.511325684798551
CR2,Complement receptor type 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30344,0.0123424631135849,0.00693919482793057,-0.00125835874915905,0.0259432849763288,0.0753471909568128
CR2,Complement receptor type 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30344,0.0142805403295425,0.00690852473930221,0.000739831840510135,0.0278212488185748,0.0387692768289805
CR2,Complement receptor type 2,Eye measures,X5264.Corneal hysteresis (left),30344,0.000894129511996583,0.00707036089634911,-0.0129637778448477,0.0147520368688408,0.89937081840484
CR2,Complement receptor type 2,Eye measures,X5265.Corneal resistance factor (left),30344,0.00885119292690709,0.00699788697151042,-0.00486466553725332,0.0225670513910675,0.205979452725965
CR2,Complement receptor type 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29922,0.127101412353493,0.207716378280914,-0.280022689077098,0.534225513784084,0.540630120843382
CR2,Complement receptor type 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52161,0.0361848988774852,0.0186569756623839,-0.000382773420787276,0.0727525711757577,0.0524526123551493
CR2,Complement receptor type 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52161,0.0433358337532201,0.0192591114267467,0.00558797535679666,0.0810836921496436,0.0244474205080299
CR2,Complement receptor type 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52161,0.026888531993245,0.0491358353926741,-0.0694177053763961,0.123194769362886,0.584226130792453
CR2,Complement receptor type 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52161,-0.00954762905408716,0.00816518445830597,-0.0255513905923669,0.00645613248419255,0.242288951480113
CR2,Complement receptor type 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52161,0.00416262547173361,0.007462270895795,-0.0104634254840246,0.0187886764274918,0.576969841194436
CR2,Complement receptor type 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37293,-0.00233898904378517,0.00935314574466153,-0.0206711547033218,0.0159931766157514,0.802533256695171
CR2,Complement receptor type 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37293,0.000237245733661491,0.0233073320712027,-0.0454451251258959,0.0459196165932189,0.991878617720586
CR2,Complement receptor type 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37293,-0.0417387453544345,0.0183061228256536,-0.0776187460927155,-0.00585874461615356,0.0226214636629762
CR2,Complement receptor type 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37293,0.00486806962756425,0.0112505973988202,-0.0171831012741234,0.0269192405292519,0.665244121114085
CR2,Complement receptor type 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52245,-0.0116989705175973,0.0153460630276591,-0.0417772540518092,0.0183793130166147,0.445861521721742
CR2,Complement receptor type 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52245,-0.0116989705175973,0.0153460630276591,-0.0417772540518092,0.0183793130166147,0.445861521721742
CR2,Complement receptor type 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52245,-0.00723776567592895,0.0123044073706992,-0.0313544041224994,0.0168788727706415,0.556385750567492
CR2,Complement receptor type 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52245,0.00824804573413259,0.0192613314462742,-0.0295041639005648,0.04600025536883,0.66849584777843
CR2,Complement receptor type 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52245,0.00987608420071399,0.047235965462467,-0.0827064081057213,0.102458576507149,0.834387509017149
CR2,Complement receptor type 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52245,-0.0296600017837706,0.0324097325826911,-0.0931830776458451,0.033863074078304,0.360117022720987
CR2,Complement receptor type 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52245,-0.0228935506203426,0.0528860924454118,-0.12655029181335,0.0807631905726646,0.665102302024144
CR2,Complement receptor type 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52161,-0.00158955197015765,0.00986910950196169,-0.0209330065940026,0.0177539026536873,0.87204466943184
CR2,Complement receptor type 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52161,0.0155576506492951,0.0165034604320227,-0.0167891317974695,0.0479044330960596,0.34584759902048
CR2,Complement receptor type 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52161,0.0027940034508593,0.00875574200085695,-0.0143672508708203,0.0199552577725389,0.749649089882565
CR2,Complement receptor type 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52161,-0.00105277185045585,0.0162457691160977,-0.0328944793180073,0.0307889356170956,0.948331453876194
CR2,Complement receptor type 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52161,-0.000265654207140902,0.0158052730115988,-0.0312439893098746,0.0307126808955928,0.986589950207871
CR2,Complement receptor type 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52161,0.0265382060978454,0.00887524822778586,0.00914271957138515,0.0439336926243057,0.00279097451350009
CR2,Complement receptor type 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31894,0.0244892566919082,0.0340893090999308,-0.0423257891439563,0.0913043025277726,0.472542334035024
CR2,Complement receptor type 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31894,-0.0167946382217802,0.0224658867687082,-0.0608277762884484,0.0272384998448879,0.454748147432496
CR2,Complement receptor type 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31894,0.0603129206063969,0.0286065369211388,0.00424410824096479,0.116381732971829,0.0350330709253017
CR2,Complement receptor type 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31894,0.0333866262751687,0.0254478877603776,-0.0164912337351714,0.0832644862855087,0.189573893297687
CR2,Complement receptor type 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52158,-0.0429069721759634,0.02418102141002,-0.0903017741396026,0.00448782978767588,0.0760068419104829
CR2,Complement receptor type 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52158,-0.0567505595579539,0.041149108710923,-0.137402812631363,0.0239016935154553,0.167861393807539
CR2,Complement receptor type 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52158,-0.00803581770072357,0.0667220393755257,-0.138811014876754,0.122739379475307,0.904137672898125
CR2,Complement receptor type 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52158,-0.0315668889249762,0.064615008947098,-0.158212306461288,0.0950785286113359,0.625172664652859
CR2,Complement receptor type 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52158,0.00401200540564452,0.0200774193971883,-0.0353397366128446,0.0433637474241337,0.841617548665284
CR2,Complement receptor type 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52158,-0.0719387801804276,0.0285449699858921,-0.127886921352776,-0.0159906390080791,0.0117346840639599
CR2,Complement receptor type 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52158,-0.00528208481516329,0.0142482856778602,-0.0332087247437693,0.0226445551134427,0.710850999474098
CR2,Complement receptor type 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33955,-0.00231506144628338,0.021566852644502,-0.0445860926295072,0.0399559697369405,0.914518741909025
CR2,Complement receptor type 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33955,-0.0210608658305098,0.0250310912828771,-0.0701218047449489,0.0280000730839293,0.400151643120555
CR2,Complement receptor type 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33955,-0.0389631038565267,0.0326280079176071,-0.102913999375037,0.0249877916619833,0.232444690405677
CR2,Complement receptor type 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33955,-0.00655158704052025,0.0112781902088057,-0.0286568398497794,0.0155536657687389,0.561316467938552
CR2,Complement receptor type 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37571,0.0129187687697521,0.0113939478733916,-0.00941336906209538,0.0352509066015997,0.256887729564594
CR2,Complement receptor type 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37571,-0.0297885944007573,0.00993833375059059,-0.0492677285519148,-0.0103094602495997,0.00272853931543788
CR2,Complement receptor type 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37571,-0.00265759712506668,0.0093291470266909,-0.0209427252973808,0.0156275310472475,0.775747989926086
CR2,Complement receptor type 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37571,0.0421787824310301,0.0223456178420963,-0.0016186285394786,0.0859761934015389,0.0591065674799281
CR2,Complement receptor type 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37571,-0.00355227071787759,0.0134385678970793,-0.029891863796153,0.0227873223603978,0.791526697908908
CR2,Complement receptor type 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37571,-0.00767141415412201,0.0156130527600325,-0.0382729975637857,0.0229301692555416,0.623189828078009
CR2,Complement receptor type 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52161,0.0416546050901526,0.0215343889390137,-0.000552797230314248,0.0838620074106195,0.053082789028404
CR2,Complement receptor type 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52161,-0.0200294138523801,0.0138357664493445,-0.0471475160930953,0.00708868838833504,0.147724927799586
CR2,Complement receptor type 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52161,0.0486303034015044,0.0538817490572502,-0.0569779247507059,0.154238531553715,0.366779213167156
CR2,Complement receptor type 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52161,-0.00437475755071449,0.0136341135625667,-0.0310976201333452,0.0223481050319163,0.748312466868601
CR2,Complement receptor type 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52161,0.0144777225190179,0.0163816475330114,-0.0176303066456845,0.0465857516837203,0.376824298530857
CR2,Complement receptor type 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52161,-0.00306657507573958,0.0184156998311099,-0.0391613467447151,0.0330281965932359,0.867749270405827
CR2,Complement receptor type 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52161,0.00364921604008362,0.0065166581063431,-0.00912343384834885,0.0164218659285161,0.575495739790068
CR2,Complement receptor type 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28836,0.0060921794815137,0.0224843994349518,-0.0379772434109919,0.0501616023740193,0.786441165472159
CR2,Complement receptor type 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28836,-0.000810439827705269,0.0298517630762854,-0.0593198954572246,0.0576990158018141,0.978342280176928
CR2,Complement receptor type 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28836,-0.0134902598338359,0.0197133242162683,-0.0521283752977218,0.02514785563005,0.493808073734353
CR2,Complement receptor type 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28836,0.0261542441135608,0.0177775482041213,-0.00868975036651683,0.0609982385936385,0.141310082580247
CR2,Complement receptor type 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52287,-0.000149469285805742,0.00744000392072827,-0.0147318769704331,0.0144329383988217,0.98397176351156
CR2,Complement receptor type 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52287,-0.0198409434600704,0.0198826913749891,-0.058811018555049,0.0191291316349082,0.318336386754547
CR2,Complement receptor type 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52287,0.0114116315399026,0.00726573566376968,-0.00282921036108601,0.0256524734408911,0.116284809714586
CR2,Complement receptor type 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52287,0.00907269096861635,0.00723563208715027,-0.00510914792219818,0.0232545298594309,0.209892307170798
CR2,Complement receptor type 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52287,0.00562017933772297,0.0104502536165463,-0.0148623177507078,0.0261026764261538,0.590717255109751
CR2,Complement receptor type 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52287,0.0176780049260085,0.00925016823568416,-0.000452324815932405,0.0358083346679495,0.0560018745646225
CR2,Complement receptor type 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52287,0.0130496722453599,0.00776618553756091,-0.00217205140825945,0.0282713958989793,0.0929064088371661
CR2,Complement receptor type 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52287,0.0315578089850776,0.0211067612606765,-0.00981144308584832,0.0729270610560036,0.134886204531738
CR2,Complement receptor type 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43597,-0.0196261316840488,0.00772698605119262,-0.0347710243443864,-0.00448123902371128,0.0110947759075258
CR2,Complement receptor type 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43597,-0.0526305747923694,0.00856015115815486,-0.0694084710623529,-0.0358526785223858,7.98572364450371e-10
CR2,Complement receptor type 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43597,0.0307209258096564,0.00859449193592359,0.0138757216152461,0.0475661300040666,0.0003517742563854
CR2,Complement receptor type 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43597,-0.00525407191756088,0.0109892059084458,-0.0267929154981146,0.0162847716629928,0.632575905165591
CR2,Complement receptor type 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43597,0.0179022110159507,0.00777878773392943,0.00265578705744899,0.0331486349744524,0.0213789275445625
CR2,Complement receptor type 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52039,-0.00407423256370517,0.00784852245448693,-0.0194573365744996,0.0113088714470892,0.603689436933075
CR2,Complement receptor type 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52039,0.0128539696741117,0.00630912944374828,0.000488075964365047,0.0252198633838583,0.0416234753662903
CR2,Complement receptor type 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52039,0.00141463174165559,0.00690032683372677,-0.0121100088524489,0.0149392723357601,0.837566307238361
CR2,Complement receptor type 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52039,-0.0184284443453665,0.0151899350526617,-0.0482007170485835,0.0113438283578504,0.225063370842137
CR2,Complement receptor type 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52051,-0.0202088802373143,0.00712851799143183,-0.0341807755005207,-0.00623698497410787,0.00458684091832791
CR2,Complement receptor type 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52051,-0.04315828548873,0.0128251496118814,-0.0682955787280176,-0.0180209922494423,0.000766120383641407
CR2,Complement receptor type 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52161,0.0100312493002991,0.00681192840651984,-0.00332013037647973,0.023382628977078,0.140870143172398
CR2,Complement receptor type 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52161,-0.00711701274265236,0.00773476525895633,-0.0222771526502068,0.00804312716490205,0.357511272824938
CR2,Complement receptor type 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52161,-0.0151929275932627,0.010129592511335,-0.0350469289154794,0.00466107372895399,0.133663165045217
CR2,Complement receptor type 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52161,-0.0131867045551904,0.0145773349721783,-0.0417582811006598,0.015384871990279,0.365683479101888
CR2,Complement receptor type 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52161,0.00958577091184814,0.0150252384404429,-0.0198636964314199,0.0390352382551162,0.523493301763846
CR2,Complement receptor type 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52161,0.0139569144990698,0.0195307686146255,-0.0243233919855961,0.0522372209837358,0.474855073192907
CR2,Complement receptor type 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40248,-0.0117427001500675,0.00445804283155905,-0.0204804640999232,-0.00300493620021172,0.00844557380587192
CR2,Complement receptor type 2,Physical activities,X864.Number of days or week walked 10+ minutes,51648,-0.0265619694746365,0.0215831647231673,-0.0688649723320444,0.0157410333827713,0.218453211836457
CR2,Complement receptor type 2,Physical activities,X874.Duration of walks,47549,0.000497515617380063,0.00350756642889319,-0.00637731458325059,0.00737234581801071,0.887207085760383
CR2,Complement receptor type 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50568,-0.0438755222273842,0.0209865076842912,-0.085009077288595,-0.00274196716617335,0.0365687532804935
CR2,Complement receptor type 2,Physical activities,X894.Duration of moderate activity,44353,-0.0264520739493611,0.0257774727096639,-0.0769759204603023,0.0240717725615802,0.304823845256382
CR2,Complement receptor type 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30478,-0.01125235576646,0.00718969255953334,-0.0253441531831453,0.00283944165022536,0.117619539487989
CR2,Complement receptor type 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50547,-0.0844780984208686,0.0217008265700464,-0.12701171849816,-0.0419444783435777,9.93191428228372e-05
CR2,Complement receptor type 2,Physical activities,X914.Duration of vigorous activity,38191,-0.00357311537971743,0.00460684053154416,-0.012602522821544,0.00545629206210911,0.437992157515818
